HCUP Methods Series Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2022 National Healthcare Quality and Disparities Report (NHQDR) |
Report #2022-01 |
Contact Information: Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality 5600 Fishers Lane Room 07W17B Mail Stop 7W25B Rockville, MD 20857 www.hcup-us.ahrq.gov For Technical Assistance with HCUP Products: Email: hcup@ahrq.gov or Phone: 1-866-290-HCUP |
Recommended Citation: Barrett M, McCarty J, Kenney T, Liang L. Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2022 National Healthcare Quality and Disparities Report (NHQDR). 2022. HCUP Methods Series Report # 2022-01 ONLINE. October 28, 2022. U.S. Agency for Healthcare Research and Quality. Available: www.hcup-us.ahrq.gov/reports/methods/methods.jsp. |
The Agency for Healthcare Research and Quality (AHRQ) Quality Indicators (QIs) were applied to the Healthcare Cost and Utilization Project (HCUP) hospital discharge data for selected measures in the National Healthcare Quality and Disparities Report (NHQDR). The report measures and tracks trends in quality and disparities in terms of patient safety, person-centered care, care coordination, effective treatment, healthy living, and care affordability - and access to health care. A focus on priority populations summarizes quality and disparities in care for populations at elevated risk for receiving poor health care, which includes HCUP-based measures related to racial, ethnic, and socioeconomic factors for priority populations, including changes over time and across the urban-rural continuum. The NHQDR provides a comprehensive overview of the quality of health care received by the general population and disparities in care experienced by different racial, ethnic, and socioeconomic groups.
The AHRQ QIs are measures of quality associated with processes of care that occur in an outpatient or an inpatient setting. The QIs rely solely on hospital inpatient administrative data and, for this reason, are screens for examining quality that may indicate the need for more in-depth studies. The AHRQ QIs include four sets of measures:
Prior to the 2018 NHQDR, the reports included longitudinal reporting of QI trends based on ICD-9-CM1 coding. Because of the transition from ICD-9-CM to ICD-10-CM/PCS2 on October 1, 2015, the 2022 NHQDR includes QI estimates for 2016, 2017, 2018, and 2019 and does not report on trends prior to 2016. The following national and State-level QI estimates were constructed from the HCUP databases for the NHQDR:
The AHRQ QI measures generated for possible inclusion in the NHQDR are described in Table 1 at the end of this methods report. The Healthcare Cost and Utilization Project (HCUP) is a family of healthcare databases and related software tools and products developed through a Federal-State-Industry partnership and sponsored by AHRQ. HCUP databases are derived from administrative data and contain encounter-level, clinical and nonclinical information including all-listed diagnoses and procedures, discharge status, patient demographics, and charges for all patients, regardless of payer (e.g., Medicare, Medicaid, private insurance, uninsured), beginning in 1988. These databases enable research on a broad range of health policy issues, including cost and quality of health services, medical practice patterns, patient safety, access to health care programs, and outcomes of treatments at the national, State and local market levels. The following HCUP databases were used as the source of data for the NHQDR:
The list of HCUP Partner organizations that contribute to the HCUP databases each year is provided in Table 2. HCUP coding includes race and ethnicity in one data element (RACE). Because of variability in the collection of race and ethnicity information in the State data, HCUP maintains a uniform set of categories based on race definitions used in the 1977 Office of Management and Budget (OMB) Directive 15 using the combined race-ethnicity format (separate categories for Hispanic and five Non-Hispanic racial groups - White, Black, Asian or Pacific Islander, American Indian or Alaska Native (AIAN), and Other). When a State and its hospitals collect Hispanic ethnicity separately from race, HCUP assigns the data to the combined race/ethnicity categorization and uses Hispanic ethnicity to override any other race category to create uniform coding across States. There is limited reporting of AIAN in the HCUP data. In addition, in some areas of the country, care for the AIAN population is provided in Indian Health Service (IHS) hospitals which are not included in HCUP. For these reasons, AIAN discharges were combined with "Other" races for the NHQDR analyses. The resulting NHQDR reporting categories for the HCUP data include: White Non-Hispanic; African American Non-Hispanic; Asian/Pacific Islander Non-Hispanic; Other Non-Hispanic; and Hispanic (of any race). Modifications to the HCUP Data In preparation for the NHQDR and its derivative products, the HCUP databases needed to be customized as indicated below:
Creation of Analysis Files Derived from the HCUP Databases Beginning with the 2022 NHQDR, two versions of the nationally weighted NHQDR analysis file were used for reporting national QI estimates. Both used the SID, but were limited to community hospitals, excluding rehabilitation and long-term acute care (LTAC) facilities. The two versions were specific to the data elements needed for the different QI modules:
Table 3 shows which SID qualified for by race/ethnicity and PSI reporting for data years 2016-2019. A comparison of the nationally weighted NHQDR analysis file to the HCUP National Inpatient Sample (NIS) data is provided in Appendix A. The editing of the race/ethnicity and POA data informed which records and States could be used for State-level reporting in the NHQDR. The HCUP SID were modified to create analytic files consistent across States.
Weighting also accounted for all discharges or hospitals excluded because of edit checks on race/ethnicity and POA. STEPS TAKEN TO APPLY AHRQ QUALITY INDICATORS TO THE HCUP DATA To apply the AHRQ Quality Indicators to HCUP hospital discharge data for the NHQDR, several steps were taken:
Review and Modify the AHRQ QI Software We used AHRQ QI software v2020.1 that features ICD-10-CM/PCS coding. The AHRQ QI software v2020.1 calculates risk-adjusted rates for a subset of hospital measures and all area-based measures. Therefore, the 2021 NHQDR includes risk-adjusted QI estimates as available in the software. The QI software was modified for the 2022 NHQDR in several ways.
Acquire Population-Based Data for Denominators The next step was to acquire data for the numerator and denominator populations for the QIs. The AHRQ QIs measure an event that occurs in a hospital, requiring a numerator count of the event of interest and a denominator count of the population (within a hospital or geographic area) to which the event relates.
Assign QI Indicators to the HCUP Databases The four AHRQ QI program modules were applied to the prepared SID data using all available diagnoses and procedures reported by each State. Adapt Statistical Methods to HCUP Data Several statistical issues needed to be addressed when applying the AHRQ QI software to the HCUP data for the NHQDR, including the derivation of standard errors for weighted data and appropriate hypothesis tests.
Some caution should be used in interpreting the QI statistics presented in the NHQDR. Appendix D details how these caveats relate to inter-State differences in data collection and other more general issues. National Inpatient Hospital Costs Associated with Quality Indicators The NHQDR includes total national costs for the select PQIs and PDIs including the composites and ambulatory care sensitive conditions such as heart failure, diabetes, and asthma. Total national costs associated with these PQIs and PDIs were calculated overall and by community income quartile and race/ethnicity. Total charges were converted to costs using the hospital-level HCUP Cost-to-Charge Ratio Files (CCR Files) based on Hospital Cost Report data from the Centers for Medicare & Medicaid Services (CMS).5 Costs reflect the actual costs of production, while charges represent what the hospital billed for the stay. Hospital charges reflect the amount the hospital charged for the entire hospital stay and do not include professional (physician) fees. To account for records with missing total charges and costs in the aggregate, the average cost for the QI was used to impute the missing values for that QI. This approach compensates for stays for which charges (and thus estimated costs) are not available. Benchmarks for State Performance for the Quality Indicators Based on a recommendation from the Institute of Medicines report on Future Directions for the National Healthcare Quality and Disparities Reports, benchmarks based on a straight average of the top 10 percent of reporting States were determined. For a benchmark to be calculated, rates for at least 30 States needed to be available. Medicaid and Uninsured Inpatient Stays and Aggregate Hospital Costs in the United States Information on Medicaid and uninsured inpatient stays and aggregate hospital costs in the United States for 20122018 were developed using the HCUP National Inpatient Sample (NIS). Medicaid and uninsured discharges were identified based on the expected primary payer of Medicaid, self-pay, no charge, and charity. Discharge counts and aggregate hospital costs were reported as a percentage of the total U.S and by hospital characteristics including region, ownership, teaching status, urban-rural location, and size of the hospital based on the number of beds. National Rates for Inpatient Stays for Select Maternal Conditions The nationally weighted NHQDR analysis file was used to examine differences in inpatient stays for select maternal conditions. Rates for the following measures were calculated for inpatient stays for women aged 12-55 years with any delivery diagnosis, procedure, or DRG, excluding those with any indication of abortion:
National Estimates of Emergency Department Utilization The NEDS was used to examine national and regional differences in ED use for selected ambulatory care sensitive conditions
Additional details on the use of the NEDS for reporting are provided in Appendix B. Table 1. AHRQ QIs Applied to the HCUP Data for the NHQDR This table includes the list of all AHRQ QI software v2020.1 QIs calculated using 2016-2019 HCUP inpatient data under the NHQDR task. Not all of the AHRQ QIs listed below were included in the NHQDR. The QI specifications are consistent with the AHRQ software. For more information on QI definitions, please visit the AHRQ QI website (https://www.qualityindicators.ahrq.gov/Default.aspx). |
QI | QI Label |
---|---|
Inpatient Quality Indicators | |
IQI08 | Deaths per 1,000 hospital admissions with esophageal resection for cancer, age 18 and over |
IQI09 | Deaths per 1,000 hospital admissions with pancreatic resection, age 18 and over |
IQI11 | Deaths per 1,000 hospital admissions with abdominal aortic aneurysm (AAA) repair, age 18 and over |
IQI12 | Deaths per 1,000 hospital admissions with coronary artery bypass graft (CABG), age 40 and over |
IQI15 | Deaths per 1,000 hospital admissions with acute myocardial infarction (AMI), age 18 and over |
IQI16 | Deaths per 1,000 hospital admissions with heart failure (HF), age 18 and over |
IQI17 | Deaths per 1,000 hospital admissions with acute stroke, age 18 and over |
IQI18 | Deaths per 1,000 hospital admissions with gastrointestinal hemorrhage, age 18 and over |
IQI19 | Deaths per 1,000 hospital admissions with hip fracture, age 65 and over |
IQI20 | Deaths per 1,000 hospital admissions with pneumonia, age 18 and over |
IQI21 | Cesarean deliveries per 1,000 deliveries |
IQI22 | Vaginal birth after cesarean (VBAC) per 1,000 women with previous cesarean deliveries, uncomplicated |
IQI30 | Deaths per 1,000 hospital admissions with percutaneous coronary intervention (PCI), age 40 and over |
IQI31 | Deaths per 1,000 hospital admissions with carotid endarterectomy (CEA), age 18 and over |
IQI32 | Deaths per 1,000 hospital admissions with acute myocardial infarction (AMI), age 18 and over |
IQI33 | First-time cesarean deliveries (identified by no previous cesarean delivery diagnosis on the record) per 1,000 deliveries |
IQI34 | Vaginal birth after cesarean (VBAC) per 1,000 women with previous cesarean deliveries, all |
Pediatric Quality Indicators | |
NQI03 | Admissions with blood stream infection per 1,000 medical and surgical discharges of length 2 or more days, newborns |
PDI01 | Accidental puncture or laceration during a procedure per 1,000 medical and surgical admissions, age less than 18 years |
PDI05 | Admissions with iatrogenic pneumothorax per 1,000 medical and surgical admissions, age less than 18 years |
PDI08 | Perioperative hemorrhage or hematoma with surgical drainage or evacuation per 1,000 elective surgical admissions, age less than 18 years |
PDI09 | Postoperative respiratory failure, prolonged mechanical ventilation, or reintubation per 1,000 elective-surgery admissions, age less than 18 years |
PDI10 | Postoperative sepsis per 1,000 surgery admissions, age less than 18 years |
PDI12 | Admissions with central venous catheter-related bloodstream infection per 1,000 medical and surgical discharges of length 2 or more days, age less than 18 years |
PDI14 | Admissions for asthma per 100,000 population, ages 2-17 |
PDI15 | Admissions with diabetes with short-term complications per 100,000 population, ages 6-17 |
PDI16 | Admissions for pediatric gastroenteritis per 100,000 population, ages 3 months to 17 years |
PDI18 | Admissions for urinary tract infection (UTI)per 100,000 population, ages 3 months to 17 years |
PDI90 | AHRQ overall Pediatric Quality Indicator (PDI) composite per 100,000 population, ages 6-17 |
PDI91 | AHRQ acute Pediatric Quality Indicator (PDI) composite per 100,000 population, ages 6-17 |
PDI92 | AHRQ chronic Pediatric Quality Indicator (PQI) composite per 100,000 population, ages 6-17 |
Prevention Quality Indicators | |
PQI01 | Admissions with diabetes with short-term complications per 100,000 population, age 18 and over |
PQI03 | Admissions with diabetes with long-term complications per 100,000 population, age 18 and over |
PQI05 | Admissions with chronic obstructive pulmonary disease (COPD)or asthma per 100,000 population, age 40 and over |
PQI07 | Admissions with hypertension per 100,000 population, age 18 and over |
PQI08 | Admissions for heart failure (HF)per 100,000 population, age 18 and over |
PQI11 | Admissions for community-acquired bacterial pneumonia per 100,000 population, age 18 and over |
PQI12 | Admissions for urinary tract infection (UTI)per 100,000 population, age 18 and over |
PQI14 | Admissions for uncontrolled diabetes without complications per 100,000 population, age 18 and over |
PQI15 | Admissions for asthma per 100,000 population, age 18 to 39 |
PQI16 | Lower extremity amputations among admissions for diabetes per 100,000 population, age 18 and over |
PQI17 | Admissions for immunization-preventable pneumococcal pneumonia per 100,000 population, age 65 and over |
PQI18 | Admissions for immunization-preventable influenza per 100,000 population, age 65 and over |
PQI90 | AHRQ overall Prevention Quality Indicator (PQI) composite per 100,000 population, age 18 and over |
PQI91 | AHRQ acute Prevention Quality Indicator (PQI) composite per 100,000 population, age 18 and over |
PQI92 | AHRQ chronic Prevention Quality Indicator (PQI) composite per 100,000 population, age 18 and over |
PQI93 | AHRQ diabetes Prevention Quality Indicator (PQI) composite per 100,000 population, age 18 and over |
Patient Safety Indicators | |
PSI02 | Deaths per 1,000 hospital admissions with expected low-mortality, age 18 and over or obstetric admissions |
PSI03 | Admissions with pressure ulcers per 1,000 medical and surgical discharges of length 3 or more days, age 18 and over |
PSI04 | Deaths per 1,000 elective-surgery admissions having developed serious treatable complications of care during hospitalization, ages 18-89 or obstetric admissions |
PSI05 | Count of retained surgical items or unretrieved device fragments among medical and surgical admissions, age 18 and over or obstetric admissions |
PSI06 | Admissions with iatrogenic pneumothorax per 1,000 medical and surgical admissions, age 18 and over |
PSI07 | Admissions with central venous catheter-related bloodstream infection per 1,000 medical and surgical discharges of length 2 or more days, age 18 and over or obstetric admissions |
PSI08 | Postoperative hip fracture per 1,000 surgical admissions who were not susceptible to falling, age 18 and over |
PSI10 | Perioperative hemorrhage or hematoma with surgical drainage or evacuation per 1,000 surgical admissions, age 18 and over |
PSI11 | Postoperative acute kidney injury requiring dialysis per 1,000 elective-surgery admissions, age 18 and over |
PSI12 | Postoperative pulmonary embolism (PE) or deep vein thrombosis (DVT) per 1,000 surgical admissions, age 18 and over |
PSI13 | Postoperative sepsis per 1,000 elective-surgery admissions, age 18 and over |
PSI14 | Reclosure of postoperative abdominal wound dehiscence per 1,000 abdominopelvic-surgery admissions of length 2 or more days, age 18 and over |
PSI15 | Accidental puncture or laceration during a procedure per 1,000 medical and surgical admissions, age 18 and over |
PSI17 | Birth trauma - injury to neonate per 1,000 live births |
PSI18 | Obstetric trauma per 1,000 instrument-assisted vaginal deliveries |
PSI19 | Obstetric trauma per 1,000 vaginal deliveries without instrument assistance |
HCUP Partner Organizations | Inclusion in the 2016 NHQDR National File | Inclusion in the 2017 NHQDR National File | Inclusion in the 2018 NHQDR National File | Inclusion in the 2019 NHQDR National File |
---|---|---|---|---|
Alaska Department of Health and Social Services and State Hospital and Nursing Home Association | Yes, subset | Yes, all | Yes, all | Yes, all |
Arizona Department of Health Services | Yes, all | Yes, all | Yes, all | Yes, all |
Arkansas Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
California Office of Statewide Health Planning & Development | Yes, all | Yes, all | Yes, all | Yes, all |
Colorado Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Connecticut Hospital Association | Yes, subset | Yes, subset | Yes, subset | Yes, subset |
Delaware Division of Public Health | No | Yes, subset | Yes, subset | Yes, subset |
District of Columbia Hospital Association | No | Yes, all | Yes, all | Yes, all |
Florida Agency for Health Care Administration | Yes, all | Yes, all | Yes, all | Yes, all |
Georgia Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Hawaii Health Information Corporation | Yes, all | Yes, all | Yes, all | Yes, all |
Illinois Department of Public Health | Yes, all | Yes, all | Yes, all | Yes, all |
Indiana Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Iowa Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Kansas Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Kentucky Cabinet for Health and Family Services | Yes, all | Yes, all | Yes, all | Yes, all |
Louisiana Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
Maine Health Data Organization | Yes, all | Yes, all | Yes, all | Yes, all |
Maryland Health Services Cost Review Commission | Yes, all | Yes, all | Yes, all | Yes, all |
Massachusetts Center for Health Information and Analysis | Yes, all | Yes, all | Yes, all | Yes, all |
Michigan Health & Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Minnesota Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Mississippi Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
Missouri Hospital Industry Data Institute | Yes, all | Yes, all | Yes, all | Yes, all |
Montana Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Nebraska Hospital Association | No | No | No | No |
Nevada Department of Health and Human Services | Yes, all | Yes, all | Yes, all | Yes, all |
New Hampshire Department of Health & Human Services | No | No | No | Yes, subset |
New Jersey Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
New Mexico Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
New York State Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
North Carolina Department of Health and Human Services | Yes, all | Yes, all | Yes, all | Yes, all |
North Dakota (data provided by the Minnesota Hospital Association) | No | Yes, all | Yes, all | Yes, all |
Ohio Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Oklahoma State Department of Health | Yes, subset | Yes, subset | Yes, subset | Yes, subset |
Oregon Association of Hospitals and Health Systems | Yes, all | Yes, all | Yes, all | Yes, all |
Pennsylvania Health Care Cost Containment Council | Yes, all | Yes, all | Yes, all | Yes, all |
Rhode Island Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
South Carolina Revenue and Fiscal Affairs Office | Yes, all | Yes, all | Yes, all | Yes, all |
South Dakota Association of Healthcare Organizations | Yes, all | Yes, all | Yes, all | Yes, all |
Tennessee Hospital Association | Yes, all | Yes, all | Yes, all | Yes, all |
Texas Department of State Health Services | Yes, all | Yes, all | Yes, all | Yes, all |
Utah Department of Health | No | No | Yes, all | Yes, all |
Vermont Association of Hospitals and Health Systems | Yes, all | Yes, all | Yes, all | Yes, all |
Virginia Health Information | Yes, all | Yes, all | Yes, all | Yes, all |
Washington State Department of Health | Yes, all | Yes, all | Yes, all | Yes, all |
West Virginia Department of Health and Human Resources, West Virginia Health Care Authority | Yes, subset | Yes, subset | Yes, subset | Yes, all |
Wisconsin Department of Health Services | Yes, subset | Yes, subset | Yes, subset | Yes, subset |
Wyoming Hospital Association | Yes, subset | Yes, subset | Yes, subset | Yes, subset |
*Yes, Subset: Subset of QIs that do not require POA reporting. |
State | Used for reporting by race/ethnicity? | Used for reporting by PSIs? |
---|---|---|
AK | 2016-2019 | 2017-2019 |
AR | 2016-2019 | 2016-2019 |
AZ | 2016-2019 | 2016-2019 |
CA | 2016-2019 | 2016-2019 |
CO | 2016-2019 | 2016-2019 |
CT | 2016-2019 | No |
DC | 2017-2019 | 2016-2019 |
DE | 2017-2019 | No |
FL | 2016-2019 | 2016-2019 |
GA | 2016-2019 | 2016-2019 |
HI | 2016-2019 | 2016-2019 |
IA | 2018-2019 | No |
IL | 2016-2019 | 2016-2019 |
IN | 2017-2019 | 2016-2019 |
KS | 2016-2019 | 2016-2019 |
KY | 2016-2019 | 2016-2019 |
LA | No | 2016-2019 |
MA | 2016-2019 | 2016-2019 |
MD | 2016-2019 | 2016-2019 |
ME | 2016-2019 | 2016-2019 |
MI | 2016-2019 | 2016-2019 |
MN | No | 2018-2019 |
MO | 2016-2019 | 2016-2019 |
MS | 2016-2019 | 2016-2019 |
MT | No | 2016-2019 |
NC | 2016-2019 | 2016-2019 |
ND | No | 2016-2019 |
NE | No | 2016-2019 |
NH | 2019 | No |
NJ | 2016-2019 | 2016-2019 |
NM | 2016-2019 | 2016-2019 |
NV | 2016-2019 | 2016-2019 |
NY | 2016-2019 | 2016-2019 |
OH | 2016-2019 | 2016-2019 |
OK | 2016-2019 | No |
OR | 2016-2019 | 2016-2019 |
PA | 2016-2019 | 2016-2019 |
RI | 2016-2019 | 2016-2019 |
SC | 2016-2019 | 2016-2019 |
SD | 2016-2019 | No |
TN | 2016-2019 | 2016-2019 |
TX | 2016-2019 | 2016-2019 |
UT | 2018-2019 | 2016-2019 |
VA | 2016-2019 | 2016-2019 |
VT | 2016-2019 | No |
WA | 2016-2019 | 2016-2019 |
WI | 2016-2019 | No |
WV | No | 2019 |
WY | 2016-2019 | No |
Agency for Healthcare Research and Quality. Inpatient Quality Indicators: Technical Specifications, AHRQ Quality Indicators, Version 2020.01 SAS. Rockville, MD: Agency for Healthcare Research and Quality, May 2020. Agency for Healthcare Research and Quality. Patient Safety Indicators: Technical Specifications, AHRQ Quality Indicators, Version 2020.01 SAS. Rockville, MD: Agency for Healthcare Research and Quality, May 2020. Agency for Healthcare Research and Quality. Pediatric Quality Indicators: Technical Specifications, AHRQ Quality Indicators, Version 2020.01 SAS. Rockville, MD: Agency for Healthcare Research and Quality, May 2020. Agency for Healthcare Research and Quality. Prevention Quality Indicators: Technical Specifications, AHRQ Quality Indicators, Version 2020.01 SAS. Rockville, MD: Agency for Healthcare Research and Quality, May 2020. Claritas. Claritas Demographic Data. Available: https://claritas.com/ HCUP Cost-to-Charge Ratio Files. Healthcare Cost and Utilization Project (HCUP). December 2020. Agency for Healthcare Research and Quality, Rockville, MD. Available: www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). 2016-2019. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/sidoverview.jsp. HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2016-2018. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/nisoverview.jsp. HCUP Nationwide Emergency Department Sample (NEDS). Healthcare Cost and Utilization Project (HCUP). 2016-2019. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/nedsoverview.jsp. Houchens R. Inferences with HCUP State Databases Final Report. HCUP Methods Series Report # 2010-05. ONLINE. October 12, 2010. U.S. Agency for Healthcare Research and Quality. Available: http://www.hcup-us.ahrq.gov/reports/methods.jsp. IOM (Institute of Medicine). Future Directions for the National Healthcare Quality and Disparities Reports. Washington, DC: The National Academies Press, 2010. APPENDICES APPENDIX A: NATIONALLY WEIGHTED ANALYSIS FILES FOR THE NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORT Beginning with the 2022 NHQDR, two versions of the nationally weighted NHQDR analysis file were used for reporting national QI estimates. Both used the SID and were limited to community hospitals, excluding rehabilitation and LTAC facilities. The two versions were specific to the data elements needed for the different QI modules:
In data year 2016, there were 49 eligible SID:
In data year 2017, there were 49 eligible SID:
In data year 2018, there were 49 eligible SID
In data year 2019, there were 49 eligible SID
Figure A-1. States Used for 2016 National QI Estimates Figure A-1 is a graphic of United States that illustrates which HCUP states were used for all 2016 national QI estimates, which HCUP states were used for a subset of 2016 national QI estimates, which HCUP states were not used for 2016 national QI estimates, and which states are not in HCUP for the 2016 data year. The following HCUP states were used for all 2016 national QI estimates: Washington, Oregon, California, Nevada, Montana, South Dakota, Arizona, Hawaii, Colorado, New Mexico, Kansas, Texas, Minnesota, Missouri, Arkansas, Louisiana, Iowa, Illinois, Mississippi, Michigan, Indiana, Kentucky, Tennessee, Georgia, Florida, Ohio, Maine, New York, Vermont, Massachusetts, Rhode Island, New Jersey, Pennsylvania, Maryland, Virginia, North Carolina, and South Carolina. The following HCUP states were used for a subset of 2016 national QI estimates: Alaska, Connecticut, Oklahoma, Wisconsin, West Virginia, and Wyoming. The following HCUP states were not used for 2016 national QI estimates: Delaware, District of Columbia, New Hampshire, Nebraska, North Dakota, and Utah. The following states are not in HCUP: Alabama and Idaho. Figure A-2. States Used for 2017 National QI Estimates Figure A-2. is a graphic of United States that illustrates which HCUP states were used for all 2017 national QI estimates, which HCUP states were used for a subset of 2017 national QI estimates, which HCUP states were not used for 2017 national QI estimates, and which states are not in HCUP for the 2017 data year. The following HCUP states were used for all 2017 national QI estimates: Alaska, Washington, Oregon, California, Nevada, Montana, North Dakota, South Dakota, Arizona, Hawaii, Colorado, New Mexico, Kansas, Texas, Minnesota, Missouri, Arkansas, Louisiana, Iowa, Illinois, Mississippi, Michigan, Indiana, Kentucky, Tennessee, Georgia, Florida, Ohio, Maine, New York, Vermont, District of Columbia, Massachusetts, Rhode Island, New Jersey, Pennsylvania, Maryland, Virginia, North Carolina, and South Carolina. The following HCUP states were used for a subset of 2017 national QI estimates: Connecticut, Delaware, Oklahoma, Wisconsin, West Virginia, and Wyoming. The following HCUP states were not used for 2017 national QI estimates: New Hampshire, Nebraska, and Utah. The following states are not in HCUP: Alabama and Idaho. Figure A-3. States Used for 2018 National QI Estimates Graphic of United States that illustrates which HCUP states were used for all 2018 national QI estimates, which HCUP states were used for a subset of 2018 national QI estimates, which HCUP states were not used for 2018 national QI estimates, and which states are not in HCUP for the 2018 data year. The following HCUP states were used for all 2018 national QI estimates: Alaska, Washington, Oregon, California, Nevada, Montana, North Dakota, South Dakota, Arizona, Hawaii, Utah, Colorado, New Mexico, Kansas, Texas, Minnesota, Missouri, Arkansas, Louisiana, Iowa, Illinois, Mississippi, Michigan, Indiana, Kentucky, Tennessee, Georgia, Florida, Ohio, Maine, New York, Vermont, District of Columbia, Massachusetts, Rhode Island, New Jersey, Pennsylvania, Maryland, Virginia, North Carolina, and South Carolina. The following HCUP states were used for a subset of 2018 national QI estimates: Connecticut, Delaware, Oklahoma, Wisconsin, West Virginia, and Wyoming. The following HCUP states were not used for 2018 national QI estimates: New Hampshire and Nebraska. The following states are not in HCUP: Alabama and Idaho. Figure A-4. States Used for 2019 National QI Estimates Graphic of United States that illustrates which HCUP states were used for all 2019 national QI estimates, which HCUP states were used for a subset of 2019 national QI estimates, which HCUP states were not used for 2019 national QI estimates, and which states are not in HCUP for the 2019 data year. The following HCUP states were used for all 2019 national QI estimates: Alaska, Washington, Oregon, California, Nevada, Montana, North Dakota, South Dakota, Arizona, Hawaii, Utah, Colorado, New Mexico, Kansas, Texas, Minnesota, Missouri, Arkansas, Louisiana, Iowa, Illinois, Mississippi, Michigan, Indiana, Kentucky, Tennessee, Georgia, Florida, Ohio, Maine, New York, Vermont, District of Columbia, Massachusetts, Rhode Island, New Jersey, Pennsylvania, Maryland, Virginia, West Virginia, North Carolina, and South Carolina. The following HCUP states were used for a subset of 2019 national QI estimates: Connecticut, Delaware, New Hampshire, Oklahoma, Wisconsin, and Wyoming. The following HCUP state was not used for 2019 national QI estimates: Nebraska. The following states are not in HCUP: Alabama and Idaho. Evaluating the 2016-2019 Nationally Weighted NHQDR Analysis File Table A-1 demonstrates the representation of the States (plus District of Columbia) used for each year by U.S. Census region. Table A-1. Geographic Representation of the NHQDR Analysis File, 2016-2019 |
Census Region | 2016 | 2017 | 2018 | 2019 | ||||
---|---|---|---|---|---|---|---|---|
All QIs | Subset of QIs | All QIs | Subset of QIs | All QIs | Subset of QIs | All QIs | Subset of QIs | |
Northeast | ||||||||
Number of States in the nationally weighted analysis file | 7 | 8 | 7 | 8 | 7 | 8 | 8 | 9 |
Number of States in the region | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
Percent of States included in the nationally weighted analysis file | 77.8% | 88.9% | 77.8% | 88.9% | 77.8% | 88.9% | 88.9% | 100% |
Midwest | ||||||||
Number of States in the nationally weighted analysis file | 9 | 10 | 10 | 11 | 10 | 11 | 10 | 11 |
Number of States in the region | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Percent of States included in the nationally weighted analysis file | 75.0% | 83.3% | 83.3% | 91.7% | 83.3% | 91.7% | 83.3% | 91.7% |
South | ||||||||
Number of States and District of Columbia in the nationally weighted analysis file | 12 | 14 | 13 | 16 | 13 | 16 | 14 | 16 |
Number of States and District of Columbia in the region | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Percent of States included in the nationally weighted analysis file | 70.6% | 82.4% | 76.5% | 94.1% | 76.5% | 94.1% | 82.4% | 94.1% |
West | ||||||||
Number of States in the nationally weighted analysis file | 9 | 11 | 10 | 11 | 11 | 12 | 11 | 12 |
Number of States in the region | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Percent of States included in the nationally weighted analysis file | 69.2% | 84.6% | 76.9% | 84.6% | 84.6% | 92.3% | 84.6% | 92.3% |
Total | ||||||||
Number of States in the nationally weighted analysis file | 37 | 43 | 40 | 46 | 41 | 47 | 42 | 48 |
Number of States and the District of Columbia in the region | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
Percent of States included in the nationally weighted analysis file | 72.5% | 84.3% | 78.4% | 90.2% | 80.4% | 92.2% | 82.4% | 94.1% |
Table A-2 compares aggregated totals of various measures as a percent of the national measure. Table A-2. Population Representation of the NHQDR Analysis File, 2016-2019 |
Measure | Percent of national population represented - 2016 | Percent of national population represented - 2017 | Percent of national population represented - 2018 | Percent of national population represented - 2019 | ||||
---|---|---|---|---|---|---|---|---|
All Other QIs | PSIs and Related PDIs | All Other QIs | PSIs and Related PDIs | All Other QIs | PSIs and Related PDIs | All Other QIs | PSIs and Related PDIs | |
Total resident population* | 95.3% | 90.2% | 96.0% | 90.9% | 97.0% | 94.3% | 97.4% | 92.4% |
Population by race/ethnicity*: | ||||||||
White | 94.4% | 88.1% | 95.1% | 88.8% | 96.3% | 92.7% | 96.9% | 90.9% |
African American | 95.1% | 92.3% | 96.4% | 93.2% | 96.5% | 94.8% | 96.6% | 93.5% |
Asian/Pacific Islander | 98.1% | 95.4% | 98.5% | 95.9% | 99.0% | 97.5% | 99.2% | 96.5% |
Hispanic | 97.8% | 95.2% | 98.1% | 95.4% | 98.8% | 97.6% | 98.9% | 96.2% |
Population by age*: | ||||||||
Population under age 18 | 95.0% | 90.0% | 95.7% | 90.7% | 96.9% | 94.5% | 97.3% | 92.5% |
Population age 18-64 | 95.4% | 90.3% | 96.1% | 91.0% | 97.0% | 93.4% | 97.4% | 92.5% |
Population over age 64 | 95.5% | 90.1% | 96.2% | 90.7% | 96.9% | 93.8% | 97.3% | 92.1% |
Population by income**: | ||||||||
Population with income under the Federal poverty level | 95.5% | 90.8% | 96.2% | 96.9% | 92.0% | 91.4% | Not Reported in 2019*** | |
*Calculated using 2016-2019 Claritas data and 1977 OMB Directive 15 race definitions (e.g. no option for selecting "two or more races"). **Calculated using Kaiser Family Foundation, statehealthfacts.org. Data Source: Urban Institute and Kaiser Commission on Medicaid and the Uninsured estimates based on the Census Bureau's American Community Survey, 2008-2019 (CPS: Annual Social and Economic Supplements), accessed September 24, 2021. ***Due to known data quality issues with the 2019 CPS ASEC data, which was collected in March 2020 just at the onset of the pandemic and experienced low response rates, the Kaiser Family Foundation has chosen not to report the 2019 data. |
To further evaluate the reliability of national estimates produced by the nationally weighted NHQDR analysis file it is compare to the respective National Inpatient Sample (NIS). Tables A.3A.33 contain the distribution of discharges in both files by key demographic and clinical data elements. Based on these analyses, the 2016-2019 nationally weighted analysis files appear to provide reliable national estimates when compared with the 2016-2019 NIS files. Table A-3. Comparison of Census Region, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
REGION | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
1: Northeast | 6,923,516.00 | 18.68 | 6,923,516.00 | 18.68 | 6,599,354.00 | 18.50 |
2: Midwest | 8,218,875.00 | 22.17 | 8,218,875.00 | 22.17 | 7,934,002.00 | 22.24 |
3: South | 14,599,676.00 | 39.39 | 14,599,676.00 | 39.39 | 14,019,051.00 | 39.30 |
4: West | 7,325,563.00 | 19.76 | 7,325,563.00 | 19.76 | 7,123,014.00 | 19.97 |
Table A-4. Comparison of Patient Age in Years at Admission, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
AGE_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 580.00 | 0.00 |
.A: Invalid | - | - | - | - | 55.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 6,475.00 | 0.02 |
0-17 | 5,553,777.03 | 14.98 | 5,501,469.87 | 14.84 | 5,479,699.44 | 15.36 |
18-44 | 8,984,366.79 | 24.24 | 8,993,052.74 | 24.26 | 8,707,322.70 | 24.41 |
45-64 | 9,202,667.30 | 24.83 | 9,218,187.47 | 24.87 | 8,784,564.17 | 24.62 |
65+ | 13,326,818.88 | 35.95 | 13,354,919.93 | 36.03 | 12,696,724.69 | 35.59 |
Note: AGE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-5. Comparison of Patient Sex, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
SEX_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 2,755.01 | 0.01 |
.A: Invalid | - | - | - | - | 504.99 | 0.00 |
.C: Inconsistent | - | - | - | - | 17,689.98 | 0.05 |
0: Male | 16,078,616.65 | 43.38 | 16,070,564.66 | 43.35 | 15,430,338.61 | 43.25 |
1: Female | 20,989,013.35 | 56.62 | 20,997,065.33 | 56.65 | 20,224,132.41 | 56.69 |
Note: SEX was imputed when missing in the SID for the NHQDR analysis file. |
Table A-6. Comparison of Expected Primary Payer, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
PAY1_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 43,669.98 | 0.12 |
.A: Invalid | - | - | - | - | 3,689.98 | 0.01 |
1: Medicare | 14,852,381.54 | 40.07 | 14,874,212.33 | 40.13 | 14,117,652.96 | 39.57 |
2: Medicaid | 8,629,190.25 | 23.28 | 8,584,130.71 | 23.16 | 8,241,463.63 | 23.10 |
3: Private Insurance | 10,906,265.95 | 29.42 | 10,920,775.63 | 29.46 | 10,720,692.57 | 30.05 |
4: Self-pay | 1,455,888.64 | 3.93 | 1,471,263.13 | 3.97 | 1,378,048.31 | 3.86 |
5: No Charge | 116,555.15 | 0.31 | 116,815.43 | 0.32 | 111,960.07 | 0.31 |
6: Other | 1,107,348.48 | 2.99 | 1,100,432.77 | 2.97 | 1,058,243.50 | 2.97 |
Note: PAY1 was imputed when missing in the SID for the NHQDR analysis file. |
Table A-7. Comparison of Community Income Quartile Based on the Patients ZIP Code, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
ZIPINC_QRTL_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 604,684.26 | 1.69 |
.A: Invalid | - | - | - | - | 2,570.01 | 0.01 |
1: First Quartile (lowest income) | 11,704,001.97 | 31.57 | 11,737,467.18 | 31.67 | 10,764,484.02 | 30.17 |
2: Second Quartile | 9,478,756.09 | 25.57 | 9,456,092.01 | 25.51 | 8,915,953.48 | 24.99 |
3: Third Quartile | 8,749,607.44 | 23.60 | 8,719,676.70 | 23.52 | 8,387,992.45 | 23.51 |
4: Fourth Quartile (highest income) | 7,135,264.50 | 19.25 | 7,154,394.11 | 19.30 | 6,999,736.78 | 19.62 |
Note: ZIPINC_QRTL was imputed when missing in the SID for the NHQDR analysis file. |
Table A-8. Comparison of Patient Race/Ethnicity, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
RACE_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 1,834,461.95 | 5.14 |
.A: Invalid | - | - | - | - | 1,094.99 | 0.00 |
1: White | 24,289,255.36 | 65.53 | 24,150,900.39 | 65.15 | 22,129,138.91 | 62.03 |
2: Black | 5,607,330.42 | 15.13 | 5,703,454.51 | 15.39 | 5,146,531.40 | 14.43 |
3: Hispanic | 4,557,685.94 | 12.30 | 4,649,835.45 | 12.54 | 4,151,120.68 | 11.64 |
4: Asian/Pacific Islander | 1,104,100.35 | 2.98 | 1,114,315.58 | 3.01 | 1,037,069.55 | 2.91 |
5: Native American | 260,304.36 | 0.70 | 200,816.20 | 0.54 | 219,704.67 | 0.62 |
6: Other | 1,248,953.57 | 3.37 | 1,248,307.88 | 3.37 | 1,156,298.85 | 3.24 |
Note: RACE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-9. Comparison of Location of Patient Residence, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
PL_NCHS_I | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 165,924.82 | 0.47 |
1: Large central metropolitan | 11,226,922.35 | 30.29 | 11,389,154.46 | 30.73 | 10,677,791.53 | 29.93 |
2: Large fringe metropolitan | 8,886,157.64 | 23.97 | 9,247,344.81 | 24.95 | 8,511,806.80 | 23.86 |
3: Medium metropolitan | 7,613,411.22 | 20.54 | 7,334,323.25 | 19.79 | 7,367,378.83 | 20.65 |
4: Small metropolitan | 3,383,121.43 | 9.13 | 3,269,632.66 | 8.82 | 3,261,307.20 | 9.14 |
5: Micropolitan (nonmetropolitan) | 3,380,294.75 | 9.12 | 3,342,235.48 | 9.02 | 3,249,516.34 | 9.11 |
6: Noncore (nonmetropolitan) | 2,577,722.61 | 6.95 | 2,484,939.34 | 6.70 | 2,441,695.47 | 6.84 |
Note: PL_NCHS was imputed when missing in the SID for the NHQDR analysis file. |
Table A-10. Comparison of Length of Stay, Number of Diagnoses and Procedures on the Record, Total Charges, and Total Cost, NHQDR Analysis File and HCUP National Inpatient Sample, 2016 |
Variable/Label | 2016 All Other QIs | 2016 PSIs and Related PDIs | 2016 NIS | ||||||
---|---|---|---|---|---|---|---|---|---|
MIN | MAX | MEAN | MIN | MAX | MEAN | MIN | MAX | MEAN | |
LOS: Length of stay (cleaned) | 0.00 | 365.00 | 4.63 | 0.00 | 365.00 | 4.61 | 0.00 | 365.00 | 4.62 |
NDX: Number of diagnoses on this record | 0.00 | 72.00 | 10.60 | 0.00 | 72.00 | 10.64 | 0.00 | 72.00 | 10.56 |
NPR: Number of procedures on this record | 0.00 | 76.00 | 1.59 | 0.00 | 76.00 | 1.59 | 0.00 | 66.00 | 1.59 |
TOTCHG: Total charges (cleaned) | 100.0 | 9,999,999.0 | 47,340.94 | 100.0 | 9,999,999.0 | 47,413.24 | 100.0 | 9,999,999.0 | 47,018.93 |
Table A-11. Comparison of Census Region, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
REGION | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
1: Northeast | 6,984,335.00 | 18.76 | 6,984,335.00 | 18.76 | 6,571,470.00 | 18.36 |
2: Midwest | 8,213,913.00 | 22.07 | 8,213,913.00 | 22.07 | 7,982,265.00 | 22.30 |
3: South | 14,615,323.00 | 39.27 | 14,615,323.00 | 39.27 | 14,063,640.00 | 39.29 |
4: West | 7,408,583.00 | 19.90 | 7,408,583.00 | 19.90 | 7,181,078.00 | 20.06 |
Table A-12. Comparison of Patient Age in Years at Admission, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
AGE_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 435.00 | 0.00 |
.A: Invalid | - | - | - | - | 10.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 1,265.00 | 0.00 |
0-17 | 5,474,031.73 | 14.71 | 5,464,430.31 | 14.68 | 5,375,835.89 | 15.02 |
18-44 | 8,866,071.45 | 23.82 | 8,871,038.24 | 23.83 | 8,569,788.74 | 23.94 |
45-64 | 9,115,592.15 | 24.49 | 9,125,049.20 | 24.52 | 8,721,412.25 | 24.36 |
65+ | 13,766,458.66 | 36.98 | 13,761,636.25 | 36.97 | 13,129,706.12 | 36.68 |
Note: AGE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-13. Comparison of Patient Sex, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
SEX_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 2,650.00 | 0.01 |
.A: Invalid | - | - | - | - | 5.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 2,095.00 | 0.01 |
0: Male | 16,250,362.63 | 43.66 | 16,246,433.12 | 43.65 | 15,607,453.13 | 43.60 |
1: Female | 20,971,791.37 | 56.34 | 20,975,720.88 | 56.35 | 20,186,249.87 | 56.39 |
Note: SEX was imputed when missing in the SID for the NHQDR analysis file. |
Table A-14. Comparison of Expected Primary Payer, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
PAY1_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 63,835.12 | 0.18 |
.A: Invalid | - | - | - | - | 830.00 | 0.00 |
1: Medicare | 15,246,467.72 | 40.96 | 15,228,431.07 | 40.91 | 14,513,926.28 | 40.54 |
2: Medicaid | 8,645,247.30 | 23.23 | 8,617,741.00 | 23.15 | 8,270,727.84 | 23.10 |
3: Private Insurance | 10,715,656.47 | 28.79 | 10,730,370.68 | 28.83 | 10,448,043.54 | 29.19 |
4: Self-pay | 1,471,977.12 | 3.95 | 1,495,626.86 | 4.02 | 1,398,840.40 | 3.91 |
5: No Charge | 108,362.93 | 0.29 | 111,545.81 | 0.30 | 104,305.26 | 0.29 |
6: Other | 1,034,442.47 | 2.78 | 1,038,438.58 | 2.79 | 997,944.56 | 2.79 |
Note: PAY1 was imputed when missing in the SID for the NHQDR analysis file. |
Table A-15. Comparison of Community Income Quartile Based on the Patients ZIP Code, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
ZIPINC_QRTL_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 579,364.49 | 1.62 |
.A: Invalid | - | - | - | - | 2,245.01 | 0.01 |
1: First Quartile (lowest income) | 11,508,876.50 | 30.92 | 11,584,894.34 | 31.12 | 10,680,030.04 | 29.83 |
2: Second Quartile | 9,826,739.29 | 26.40 | 9,796,986.05 | 26.32 | 9,312,561.02 | 26.01 |
3: Third Quartile | 8,649,828.57 | 23.24 | 8,574,265.96 | 23.04 | 8,277,358.70 | 23.12 |
4: Fourth Quartile (highest income) | 7,236,709.63 | 19.44 | 7,266,007.65 | 19.52 | 6,946,893.73 | 19.41 |
Note: ZIPINC_QRTL was imputed when missing in the SID for the NHQDR analysis file. |
Table A-16. Comparison of Patient Race/Ethnicity, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
RACE_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 1,531,207.63 | 4.28 |
.A: Invalid | - | - | - | - | 450.00 | 0.00 |
1: White | 24,186,983.23 | 64.98 | 23,991,274.17 | 64.45 | 22,225,089.88 | 62.08 |
2: Black | 5,618,280.55 | 15.09 | 5,738,831.71 | 15.42 | 5,249,741.85 | 14.66 |
3: Hispanic | 4,679,977.48 | 12.57 | 4,773,186.77 | 12.82 | 4,280,847.52 | 11.96 |
4: Asian/Pacific Islander | 1,152,048.96 | 3.10 | 1,159,513.86 | 3.12 | 1,068,493.25 | 2.98 |
5: Native American | 258,863.09 | 0.70 | 227,453.29 | 0.61 | 221,530.40 | 0.62 |
6: Other | 1,326,000.69 | 3.56 | 1,331,894.20 | 3.58 | 1,221,092.47 | 3.41 |
Note: RACE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-17. Comparison of Location of Patient Residence, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
PL_NCHS_I | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 165,789.53 | 0.46 |
1: Large central metropolitan | 11,280,064.76 | 30.30 | 11,460,507.19 | 30.79 | 10,700,675.23 | 29.89 |
2: Large fringe metropolitan | 8,990,496.52 | 24.15 | 9,318,283.84 | 25.03 | 8,607,932.94 | 24.05 |
3: Medium metropolitan | 7,567,370.83 | 20.33 | 7,283,783.59 | 19.57 | 7,359,152.85 | 20.56 |
4: Small metropolitan | 3,436,245.52 | 9.23 | 3,327,373.68 | 8.94 | 3,274,419.19 | 9.15 |
5: Micropolitan (nonmetropolitan) | 3,380,549.99 | 9.08 | 3,344,245.50 | 8.98 | 3,253,851.51 | 9.09 |
6: Noncore (nonmetropolitan) | 2,567,426.37 | 6.90 | 2,487,960.20 | 6.68 | 2,436,631.76 | 6.81 |
Note: PL_NCHS was imputed when missing in the SID for the NHQDR analysis file. |
Table A-18. Comparison of Length of Stay, Number of Diagnoses and Procedures on the Record, Total Charges, and Total Cost, NHQDR Analysis File and HCUP National Inpatient Sample, 2017 |
Variable/Label | 2017 All Other QIs | 2017 PSIs and Related PDIs | 2017 NIS | ||||||
---|---|---|---|---|---|---|---|---|---|
MIN | MAX | MEAN | MIN | MAX | MEAN | MIN | MAX | MEAN | |
LOS: Length of stay (cleaned) | 0.00 | 365.00 | 4.62 | 0.00 | 365.00 | 4.60 | 0.00 | 365.00 | 4.62 |
NDX: Number of diagnoses on this record | 0.00 | 111.00 | 11.35 | 0.00 | 111.00 | 11.40 | 0.00 | 104.00 | 11.32 |
NPR: Number of procedures on this record | 0.00 | 100.00 | 1.60 | 0.00 | 100.00 | 1.61 | 0.00 | 100.00 | 1.60 |
TOTCHG: Total charges (cleaned) | 100.0 | 9,999,999.0 | 49,959.22 | 100.0 | 9,999,999.0 | 50,137.08 | 100.0 | 9,999,999.0 | 49,787.58 |
Table A-19. Comparison of Census Region, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
REGION | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
1: Northeast | 6,949,008.00 | 18.70 | 6,949,008.00 | 18.70 | 6,466,741.00 | 18.20 |
2: Midwest | 8,187,106.00 | 22.03 | 8,187,106.00 | 22.03 | 7,908,637.00 | 22.26 |
3: South | 14,634,686.00 | 39.37 | 14,634,686.00 | 39.37 | 14,028,693.00 | 39.49 |
4: West | 7,399,129.00 | 19.91 | 7,399,129.00 | 19.91 | 7,123,410.00 | 20.05 |
Table A-20. Comparison of Patient Age in Years at Admission, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
AGE_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | 9.34 | 0.00 | - | - | 435.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 925.00 | 0.00 |
0-17 | 5,411,921.35 | 14.56 | 5,386,442.28 | 14.49 | 5,266,258.29 | 14.82 |
18-44 | 8,817,571.37 | 23.72 | 8,824,944.03 | 23.74 | 8,438,858.29 | 23.75 |
45-64 | 9,012,133.16 | 24.25 | 9,026,816.71 | 24.29 | 8,582,643.71 | 24.16 |
65+ | 13,928,293.77 | 37.47 | 13,931,725.98 | 37.48 | 13,238,360.71 | 37.26 |
Note: AGE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-21. Comparison of Patient Sex, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
SEX_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 2,515.00 | 0.01 |
.A: Invalid | - | - | - | - | 100.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 2,295.00 | 0.01 |
0: Male | 16,341,941.99 | 43.97 | 16,338,514.14 | 43.96 | 15,593,671.49 | 43.89 |
1: Female | 20,827,987.01 | 56.03 | 20,831,414.86 | 56.04 | 19,928,899.51 | 56.09 |
Note: SEX was imputed when missing in the SID for the NHQDR analysis file. |
Table A-22. Comparison of Expected Primary Payer, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
PAY1_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 47,569.78 | 0.13 |
.A: Invalid | - | - | - | - | 1,744.99 | 0.00 |
1: Medicare | 15,318,514.50 | 41.21 | 15,308,154.18 | 41.18 | 14,534,046.06 | 40.91 |
2: Medicaid | 8,468,101.65 | 22.78 | 8,435,461.01 | 22.69 | 8,064,974.81 | 22.70 |
3: Private Insurance | 10,689,320.11 | 28.76 | 10,705,391.33 | 28.80 | 10,307,345.49 | 29.01 |
4: Self-pay | 1,557,109.68 | 4.19 | 1,585,748.89 | 4.27 | 1,470,850.21 | 4.14 |
5: No Charge | 116,819.07 | 0.31 | 118,925.25 | 0.32 | 112,214.89 | 0.32 |
6: Other | 1,020,063.98 | 2.74 | 1,016,248.35 | 2.73 | 988,734.78 | 2.78 |
Note: PAY1 was imputed when missing in the SID for the NHQDR analysis file. |
Table A-23. Comparison of Community Income Quartile Based on the Patients ZIP Code, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
ZIPINC_QRTL_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 590,199.71 | 1.66 |
.A: Invalid | - | - | - | - | 1,725.00 | 0.00 |
1: First Quartile (lowest income) | 11,137,345.55 | 29.96 | 11,180,244.09 | 30.08 | 10,295,751.57 | 28.98 |
2: Second Quartile | 9,911,772.17 | 26.67 | 9,851,110.54 | 26.50 | 9,398,242.99 | 26.45 |
3: Third Quartile | 8,774,141.01 | 23.61 | 8,740,305.05 | 23.51 | 8,330,567.44 | 23.45 |
4: Fourth Quartile (highest income) | 7,346,670.26 | 19.77 | 7,398,269.33 | 19.90 | 6,910,994.29 | 19.45 |
Note: ZIPINC_QRTL was imputed when missing in the SID for the NHQDR analysis file. |
Table A-24. Comparison of Patient Race/Ethnicity, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
RACE_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 1,186,458.10 | 3.34 |
.A: Invalid | - | - | - | - | 324.99 | 0.00 |
1: White | 24,032,257.41 | 64.66 | 23,881,542.45 | 64.25 | 22,191,103.49 | 62.46 |
2: Black | 5,587,006.86 | 15.03 | 5,677,917.38 | 15.28 | 5,208,276.66 | 14.66 |
3: Hispanic | 4,814,647.51 | 12.95 | 4,905,955.17 | 13.20 | 4,404,648.69 | 12.40 |
4: Asian/Pacific Islander | 1,149,612.51 | 3.09 | 1,151,075.52 | 3.10 | 1,074,254.31 | 3.02 |
5: Native American | 259,151.84 | 0.70 | 224,976.72 | 0.61 | 230,139.47 | 0.65 |
6: Other | 1,327,252.86 | 3.57 | 1,328,461.76 | 3.57 | 1,232,275.29 | 3.47 |
Note: RACE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-25. Comparison of Location of Patient Residence, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
PL_NCHS_I | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 186,070.40 | 0.52 |
1: Large central metropolitan | 11,366,157.77 | 30.58 | 11,510,311.01 | 30.97 | 10,641,351.84 | 29.95 |
2: Large fringe metropolitan | 8,909,031.37 | 23.97 | 9,189,246.88 | 24.72 | 8,459,544.44 | 23.81 |
3: Medium metropolitan | 7,630,849.16 | 20.53 | 7,433,070.03 | 20.00 | 7,347,307.30 | 20.68 |
4: Small metropolitan | 3,396,379.77 | 9.14 | 3,286,837.78 | 8.84 | 3,285,610.22 | 9.25 |
5: Micropolitan (nonmetropolitan) | 3,339,967.58 | 8.99 | 3,299,709.16 | 8.88 | 3,217,495.23 | 9.06 |
6: Noncore (nonmetropolitan) | 2,527,543.34 | 6.80 | 2,450,754.14 | 6.59 | 2,390,101.57 | 6.73 |
Note: PL_NCHS was imputed when missing in the SID for the NHQDR analysis file. |
Table A-26. Comparison of Length of Stay, Number of Diagnoses and Procedures on the Record, Total Charges, and Total Cost, NHQDR Analysis File and HCUP National Inpatient Sample, 2018 |
Variable/Label | 2018 All Other QIs | 2018 PSIs and Related PDIs | 2018 NIS | ||||||
---|---|---|---|---|---|---|---|---|---|
MIN | MAX | MEAN | MIN | MAX | MEAN | MIN | MAX | MEAN | |
LOS: Length of stay (cleaned) | 0.00 | 365.00 | 4.66 | 0.00 | 365.00 | 4.64 | 0.00 | 365.00 | 4.66 |
NDX: Number of diagnoses on this record | 0.00 | 104.00 | 11.78 | 0.00 | 104.00 | 11.83 | 0.00 | 97.00 | 11.76 |
NPR: Number of procedures on this record | 0.00 | 127.00 | 1.64 | 0.00 | 127.00 | 1.64 | 0.00 | 100.00 | 1.64 |
TOTCHG: Total charges (cleaned) | 100.0 | 9,999,999.0 | 53,227.66 | 100.0 | 9,999,999.0 | 53,305.26 | 100.0 | 9,999,999.0 | 52,947.85 |
Table A-27. Comparison of Census Region, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
REGION | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
1: Northeast | 6,864,301.00 | 18.58 | 6,864,301.00 | 18.58 | 6,407,407.00 | 18.09 |
2: Midwest | 8,060,040.00 | 21.82 | 8,060,040.00 | 21.82 | 7,840,492.00 | 22.14 |
3: South | 14,713,635.00 | 39.84 | 14,713,635.00 | 39.84 | 14,076,484.00 | 39.74 |
4: West | 7,296,955.00 | 19.76 | 7,296,955.00 | 19.76 | 7,094,060.00 | 20.03 |
Table A-28. Comparison of Patient Age in Years at Admission, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
AGE_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | 6.18 | 0.00 | 1.02 | 0.00 | 335.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 954.99 | 0.00 |
0-17 | 5,308,435.13 | 14.37 | 5,275,173.69 | 14.28 | 5,199,464.51 | 14.68 |
18-44 | 8,673,836.32 | 23.48 | 8,677,097.36 | 23.49 | 8,356,283.95 | 23.59 |
45-64 | 8,858,867.14 | 23.99 | 8,876,542.65 | 24.03 | 8,440,830.71 | 23.83 |
65+ | 14,093,786.14 | 38.16 | 14,106,116.27 | 38.19 | 13,421,153.83 | 37.89 |
Note: AGE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-29. Comparison of Patient Sex, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
SEX_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 2,805.00 | 0.01 |
.A: Invalid | - | - | - | - | 180.00 | 0.00 |
.C: Inconsistent | - | - | - | - | 2,710.00 | 0.01 |
0: Male | 16,350,739.40 | 44.27 | 16,347,906.27 | 44.26 | 15,641,904.81 | 44.16 |
1: Female | 20,584,191.60 | 55.73 | 20,587,024.74 | 55.74 | 19,771,423.19 | 55.82 |
Note: SEX was imputed when missing in the SID for the NHQDR analysis file. |
Table A-30. Comparison of Expected Primary Payer, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
PAY1_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 42,179.44 | 0.12 |
.A: Invalid | - | - | - | - | 1,945.00 | 0.01 |
1: Medicare | 15,283,246.87 | 41.38 | 15,288,441.86 | 41.39 | 14,529,614.46 | 41.02 |
2: Medicaid | 8,303,257.43 | 22.48 | 8,293,568.74 | 22.45 | 7,927,119.27 | 22.38 |
3: Private Insurance | 10,551,344.71 | 28.57 | 10,557,434.39 | 28.58 | 10,249,100.57 | 28.94 |
4: Self-pay | 1,615,464.23 | 4.37 | 1,620,912.78 | 4.39 | 1,525,964.66 | 4.31 |
5: No Charge | 112,389.86 | 0.30 | 113,575.21 | 0.31 | 109,379.93 | 0.31 |
6: Other | 1,069,227.89 | 2.89 | 1,060,998.02 | 2.87 | 1,033,719.66 | 2.92 |
Note: PAY1 was imputed when missing in the SID for the NHQDR analysis file. |
Table A-31. Comparison of Community Income Quartile Based on the Patients ZIP Code, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
ZIPINC_QRTL_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 591,360.66 | 1.67 |
.A: Invalid | - | - | - | - | 2,025.00 | 0.01 |
1: First Quartile (lowest income) | 11,488,019.79 | 31.10 | 11,599,037.38 | 31.40 | 10,584,319.17 | 29.88 |
2: Second Quartile | 9,338,682.25 | 25.28 | 9,306,340.11 | 25.20 | 8,811,370.52 | 24.88 |
3: Third Quartile | 8,907,237.56 | 24.12 | 8,826,705.39 | 23.90 | 8,494,419.67 | 23.98 |
4: Fourth Quartile (highest income) | 7,200,991.40 | 19.50 | 7,202,848.12 | 19.50 | 6,935,527.97 | 19.58 |
Note: ZIPINC_QRTL was imputed when missing in the SID for the NHQDR analysis file. |
Table A-32. Comparison of Patient Race/Ethnicity, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
RACE_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 1,131,754.09 | 3.20 |
.A: Invalid | - | - | - | - | 190.00 | 0.00 |
1: White | 23,937,952.75 | 64.81 | 23,858,165.35 | 64.60 | 22,259,442.29 | 62.85 |
2: Black | 5,661,855.17 | 15.33 | 5,708,396.97 | 15.46 | 5,277,195.01 | 14.90 |
3: Hispanic | 4,630,576.39 | 12.54 | 4,684,025.35 | 12.68 | 4,244,035.26 | 11.98 |
4: Asian/Pacific Islander | 1,147,277.58 | 3.11 | 1,149,260.01 | 3.11 | 1,071,470.14 | 3.03 |
5: Native American | 268,285.47 | 0.73 | 223,419.99 | 0.60 | 241,940.30 | 0.68 |
6: Other | 1,288,983.64 | 3.49 | 1,311,663.33 | 3.55 | 1,192,995.91 | 3.37 |
Note: RACE was imputed when missing in the SID for the NHQDR analysis file. |
Table A-33. Comparison of Location of Patient Residence, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
PL_NCHS_I | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | |||
---|---|---|---|---|---|---|
Frequency | Percent | Frequency | Percent | Frequency | Percent | |
.: Missing | - | - | - | - | 203,365.27 | 0.57 |
1: Large central metropolitan | 11,161,738.40 | 30.22 | 11,244,418.39 | 30.44 | 10,432,019.02 | 29.45 |
2: Large fringe metropolitan | 8,854,605.49 | 23.97 | 9,110,468.65 | 24.67 | 8,546,404.17 | 24.13 |
3: Medium metropolitan | 7,682,420.25 | 20.80 | 7,424,692.41 | 20.10 | 7,406,801.60 | 20.91 |
4: Small metropolitan | 3,380,869.13 | 9.15 | 3,365,111.02 | 9.11 | 3,265,565.97 | 9.22 |
5: Micropolitan (nonmetropolitan) | 3,361,676.59 | 9.10 | 3,327,768.43 | 9.01 | 3,209,126.27 | 9.06 |
6: Noncore (nonmetropolitan) | 2,493,621.14 | 6.75 | 2,462,472.10 | 6.67 | 2,355,740.69 | 6.65 |
Note: PL_NCHS was imputed when missing in the SID for the NHQDR analysis file. |
Table A-34. Comparison of Length of Stay, Number of Diagnoses and Procedures on the Record, Total Charges, and Total Cost, NHQDR Analysis File and HCUP National Inpatient Sample, 2019 |
Variable/Label | 2019 All Other QIs | 2019 PSIs and Related PDIs | 2019 NIS | ||||||
---|---|---|---|---|---|---|---|---|---|
MIN | MAX | MEAN | MIN | MAX | MEAN | MIN | MAX | MEAN | |
LOS: Length of stay (cleaned) | 0.00 | 365.00 | 4.70 | 0.00 | 365.00 | 4.69 | 0.00 | 365.00 | 4.70 |
NDX: Number of diagnoses on this record | 0.00 | 110.00 | 12.22 | 0.00 | 110.00 | 12.27 | 0.00 | 108.00 | 12.19 |
NPR: Number of procedures on this record | 0.00 | 143.00 | 1.65 | 0.00 | 143.00 | 1.66 | 0.00 | 100.00 | 1.66 |
TOTCHG: Total charges (cleaned) | 100.0 | 9,999,999.0 | 56,753.83 | 100.0 | 9,999,999.0 | 56,720.06 | 100.0 | 9,980,202.0 | 56,614.05 |
ICD-10-CM DIAGNOSIS | DESCRIPTION |
---|---|
'F064' | Anxiety disorder due to known physiological condition |
'F4000' | Agoraphobia, unspecified |
'F4001' | Agoraphobia with panic disorder |
'F4002' | Agoraphobia without panic disorder |
'F4010' | Social phobia, unspecified |
'F4011' | Social phobia, generalized |
'F40210' | Arachnophobia |
'F40218' | Other animal type phobia |
'F40220' | Fear of thunderstorms |
'F40228' | Other natural environment type phobia |
'F40230' | Fear of blood |
'F40231' | Fear of injections and transfusions |
'F40232' | Fear of other medical care |
'F40233' | Fear of injury |
'F40240' | Claustrophobia |
'F40241' | Acrophobia |
'F40242' | Fear of bridges |
'F40243' | Fear of flying |
'F40248' | Other situational type phobia |
'F40290' | Androphobia |
'F40291' | Gynephobia |
'F40298' | Other specified phobia |
'F408' | Other phobic anxiety disorders |
'F409' | Phobic anxiety disorder, unspecified |
410' | Panic disorder [episodic paroxysmal anxiety] |
'F411' | Generalized anxiety disorder |
'F413' | Other mixed anxiety disorders |
'F418' | Other specified anxiety disorders |
'F419' | Anxiety disorder, unspecified |
'F422' | Mixed obsessional thoughts and acts |
'F423' | Hoarding disorder |
'F424' | Excoriation (skin-picking) disorder |
'F428' | Other obsessive-compulsive disorder |
'F429' | Obsessive-compulsive disorder, unspecified |
'F4311' | Post-traumatic stress disorder, acute |
'F4312' | Post-traumatic stress disorder, chronic |
'F930' | Separation anxiety disorder of childhood |
'F940' | Selective mutism |
'R466' | Undue concern and preoccupation with stressful events |
'F0633' | Mood disorder due to known physiol cond w manic features |
'F0634' | Mood disorder due to known physiol cond w mixed features |
'F3010' | Manic episode without psychotic symptoms, unspecified |
'F3011' | Manic episode without psychotic symptoms, mild |
'F3012' | Manic episode without psychotic symptoms, moderate |
'F3013' | Manic episode, severe, without psychotic symptoms |
'F302' | Manic episode severe with psychotic symptoms |
'F303' | Manic episode in partial remission |
'F308' | Other manic episodes |
'F309' | Manic episode, unspecified |
'F310' | Bipolar disorder, current episode hypomanic |
'F3110' | Bipolar disord, crnt episode manic w/o psych features, unsp |
'F3111' | Bipolar disord, crnt episode manic w/o psych features, mild |
'F3112' | Bipolar disord, episode manic w/o psych features, mod |
'F3113' | Bipolar disord, crnt epsd manic w/o psych features, severe |
'F312' | Bipolar disord, crnt episode manic severe w psych features |
'F3130' | Bipolar disord, crnt epsd depress, mild or mod severt, unsp |
'F3131' | Bipolar disorder, current episode depressed, mild |
'F3132' | Bipolar disorder, current episode depressed, moderate |
'F314' | Bipolar disord, crnt epsd depress, sev, w/o psych features |
'F315' | Bipolar disord, crnt epsd depress, severe, w psych features |
'F3160' | Bipolar disorder, current episode mixed, unspecified |
'F3161' | Bipolar disorder, current episode mixed, mild |
'F3162' | Bipolar disorder, current episode mixed, moderate |
'F3163' | Bipolar disord, crnt epsd mixed, severe, w/o psych features |
'F3164' | Bipolar disord, crnt episode mixed, severe, w psych features |
'F3171' | Bipolar disord, in partial remis, most recent epsd hypomanic |
'F3173' | Bipolar disord, in partial remis, most recent episode manic |
'F3175' | Bipolar disord, in partial remis, most recent epsd depress |
'F3177' | Bipolar disord, in partial remis, most recent episode mixed |
'F3181' | Bipolar II disorder |
'F3189' | Other bipolar disorder |
'F319' | Bipolar disorder, unspecified |
'F340' | Cyclothymic disorder |
'F0630' | Mood disorder due to known physiological condition, unsp |
'F0631' | Mood disorder due to physiol cond w depressv features |
'F0632' | Mood disord d/t physiol cond w major depressive-like epsd |
'F320' | Major depressive disorder, single episode, mild |
'F321' | Major depressive single episode, moderate |
'F322' | Major depressv single epsd, sev w/o psych features |
'F323' | Major depressv disord, single epsd, severe w psych features |
'F324' | Major depressv disorder, single episode, in partial remis |
'F328' | Other depressive episodes |
'F3281' | Premenstrual dysphoric disorder |
'F3289' | Other specified depressive episodes |
'F329' | Major depressive disorder, single episode, unspecified |
'F330' | Major depressive disorder, recurrent, mild |
'F331' | Major depressive disorder, recurrent, moderate |
'F332' | Major depressv disorder, recurrent severe w/o psych features |
'F333' | Major depressv disorder, recurrent, severe w psych symptoms |
'F3341' | Major depressive disorder, recurrent, in partial remission |
'F338' | Other recurrent disorders |
'F339' | Major depressive disorder, recurrent, unspecified |
'F341' | Dysthymic disorder |
'F348' | Other persistent mood [affective] disorders |
'F3481' | Disruptive mood dysregulation disorder |
'F3489' | Other specified persistent mood disorders |
'F349' | Persistent mood [affective] disorder, unspecified |
'F39' | Unspecified mood [affective] disorder |
'O906' | Postpartum mood disturbance |
'F631' | Pyromania |
'F632' | Kleptomania |
'F6381' | Intermittent explosive disorder |
'F6389' | Other impulse disorders |
'F639' | Impulse disorder, unspecified |
'F910' | Conduct disorder confined to family context |
'F911' | Conduct disorder, childhood-onset type |
'F912' | Conduct disorder, adolescent-onset type |
'F913' | Oppositional defiant disorder |
'F918' | Other conduct disorders |
'F919' | Conduct disorder, unspecified |
'F440' | Dissociative amnesia |
'F441' | Dissociative fugue |
'F442' | Dissociative stupor |
'F4481' | Dissociative identity disorder |
'F4489' | Other dissociative and conversion disorders |
'F449' | Dissociative and conversion disorder, unspecified |
'F481' | Depersonalization-derealization syndrome |
'F5000' | Anorexia nervosa, unspecified |
'F5001' | Anorexia nervosa, restricting type |
'F5002' | Anorexia nervosa, binge eating/purging type |
'F502' | Bulimia nervosa |
'F508' | Other eating disorders |
'F5081' | Binge eating disorder |
'F5082' | Avoidant/restrictive food intake disorder |
'F5089' | Other specified eating disorder |
'F509' | Eating disorder, unspecified |
'F9821' | Rumination disorder of infancy |
'F9829' | Other feeding disorders of infancy and early childhood |
'F983' | Pica of infancy and childhood |
'F980' | Enuresis not due to a substance or known physiol condition |
'F981' | Encopresis not due to a substance or known physiol condition |
'F641' | Dual role transvestism |
'F642' | Gender identity of childhood |
'F648' | Other sex identity disorders |
'F649' | Gender identity disorder, unspecified |
'F938' | Other childhood emotional disorders |
'R45850' | Homicidal ideations |
'F0150' | Vascular dementia without behavioral disturbance |
'F0151' | Vascular dementia with behavioral disturbance |
'F0280' | Dementia in oth diseases classd elswhr w/o behavrl disturb |
'F0281' | Dementia in oth diseases classd elswhr w behavioral disturb |
'F0390' | Unspecified dementia without behavioral disturbance |
'F0391' | Unspecified with behavioral disturbance |
'F04' | Amnestic disorder due to known physiological condition |
'F05' | Delirium due to known physiological condition |
'F0781' | Postconcussional syndrome |
'F0789' | Oth personality & behavrl disord due to known physiol cond |
'F079' | Unsp personality & behavrl disord due to known physiol cond |
'F482' | Pseudobulbar affect |
'G300' | Alzheimer's disease with early onset |
'G301' | Alzheimer's disease with late onset |
'G308' | Other Alzheimer's disease |
'G309' | Alzheimer's disease, unspecified |
'G3101' | Pick's disease |
'G3109' | Other frontotemporal dementia |
'G311' | Senile degeneration of brain, not elsewhere classified |
'G3183' | Dementia with Lewy bodies |
'R4181' | Age-related cognitive decline |
'R54' | e-related physical debility |
'F70' | Mild intellectual disabilities |
'F71' | Moderate intellectual disabilities |
'F72' | Severe intellectual disabilities |
'F73' | Profound intellectual disabilities |
'F78' | Other intellectual disabilities |
'F79' | Unspecified intellectual disabilities |
'F800' | Phonological disorder |
'F801' | Expressive language disorder |
'F802' | Mixed receptive-expressive language disorder |
'F804' | Speech and language development delay due to hearing loss |
'F8081' | Childhood onset fluency disorder |
'F8082' | Social pragmatic communication disorder |
'F8089' | Other developmental disorders of speech and language |
'F809' | Developmental disorder of speech and language, unspecified |
'F810' | Specific reading disorder |
'F812' | Mathematics disorder |
'F8181' | Disorder of written expression |
'F8189' | Other developmental disorders of scholastic skills |
'F819' | Developmental disorder of scholastic skills, unspecified |
'F82' | Specific developmental disorder of motor function |
'F840' | Autistic disorder |
'F842' | Rett's syndrome |
'F843' | Other childhood disintegrative disorder |
'F845' | Asperger's syndrome |
F848' | Other pervasive developmental disorders |
'F849' | Pervasive developmental disorder, unspecified |
'F88' | Other disorders of psychological development |
'F89' | Unspecified disorder of psychological development |
'F900' | Attn-defct hyperactivity disorder, predom inattentive type |
'F901' | Attn-defct disorder, predom hyperactive type |
'F902' | Attention-deficit hyperactivity disorder, combined type |
'F908' | Attention-deficit hyperactivity disorder, other type |
'F909' | Attention-deficit hyperactivity disorder, unspecified type |
'F948' | Other childhood disorders of social functioning |
'F949' | Childhood disorder of social functioning, unspecified |
'F950' | Transient tic disorder |
'F951' | Chronic motor or vocal tic disorder |
'F952' | Tourette's disorder |
'F958' | Other tic disorders |
'F959' | Tic disorder, unspecified |
'F984' | Stereotyped movement disorders |
'F985' | Adult onset fluency disorder |
'R480' | Dyslexia and alexia |
'F42' | Obsessive-compulsive disorder |
'F4521' | Hypochondriasis |
'F4522' | Body dysmorphic disorder |
'F633' | Trichotillomania |
'R4681' | Obsessive-compulsive behavior |
'F068' | Oth mental disorders due to known physiological condition |
'F09' | Unsp mental due to known physiological condition |
'F488' | Other specified nonpsychotic mental disorders |
'F489' | Nonpsychotic mental disorder, unspecified |
'F939' | Childhood emotional disorder, unspecified |
'F99' | Mental disorder, not otherwise specified |
'F650' | Fetishism |
'F651' | Transvestic fetishism |
'F652' | Exhibitionism |
'F653' | Voyeurism |
'F654' | Pedophilia |
'F6551' | Sexual masochism |
'F6552' | Sexual sadism |
'F6581' | Frotteurism |
'F6589' | Other paraphilias |
'F659' | Paraphilia, unspecified |
'F070' | Personality change due to known physiological condition |
'F21' | Schizotypal disorder |
'F600' | Paranoid personality disorder |
'F601' | Schizoid personality disorder |
'F602' | Antisocial personality disorder |
'F603' | Borderline personality disorder |
'F604' | Histrionic personality disorder |
'F605' | Obsessive-compulsive personality disorder |
'F606' | Avoidant personality disorder |
'F607' | Dependent personality disorder |
'F6081' | Narcissistic personality disorder |
'F6089' | Other specific personality disorders |
'F609' | Personality disorder, unspecified |
'F6811' | Factitious disorder w predom psych signs and symptoms |
'F6812' | Factitious disorder w predom physical signs and symptoms |
'F6813' | Factitious disord w comb psych and physcl signs and symptoms |
'F688' | Other specified disorders of adult personality and behavior |
'F69' | Unspecified disorder of adult personality and behavior |
'F060' | Psychotic disorder w hallucin due to known physiol condition |
'F061' | Catatonic due to known physiological condition |
'F062' | Psychotic disorder w delusions due to known physiol cond |
'F200' | Paranoid schizophrenia |
'F201' | Disorganized schizophrenia |
'F202' | Catatonic schizophrenia |
'F203' | Undifferentiated schizophrenia |
'F205' | Residual schizophrenia |
'F2081' | Schizophreniform disorder |
'F2089' | Other schizophrenia |
'F209' | Schizophrenia, unspecified |
'F22' | Delusional disorders |
'F23' | Brief psychotic disorder |
'F24' | Shared psychotic disorder |
'F250' | Schizoaffective disorder bipolar type |
'F251' | Schizoaffective disorder, depressive type |
'F258' | Other schizoaffective disorders |
'F259' | Schizoaffective disorder, unspecified |
'F28' | Oth psych disorder not due to a sub or known physiol cond |
'F29' | Unsp psychosis not due to a substance or known physiol cond |
'F520' | Hypoactive sexual desire disorder |
'F521' | Sexual aversion disorder |
'F5221' | Male erectile disorder |
'F5222' | Female sexual arousal disorder |
'F5231' | Female orgasmic disorder |
'F5232' | Male orgasmic disorder |
'F524' | Premature ejaculation |
'F525' | Vaginismus not due to a substance or physiol condition |
'F526' | Dyspareunia not due to a substance or known physiol cond |
'F528' | Oth sexual dysfnct not due to a sub or known physiol cond |
'F529' | Unsp sexual dysfnct not due to a sub or known physiol cond |
'F53' | Puerperal psychosis |
'F640' | Transsexualism |
'F6550' | Sadomasochism, unspecified |
'F66' | Other sexual disorders |
'R37' | Sexual dysfunction, unspecified |
'F5101' | Primary insomnia |
'F5102' | Adjustment insomnia |
'F5103' | Paradoxical insomnia |
'F5104' | Psychophysiologic insomnia |
'F5105' | Insomnia due to other mental disorder |
'F5109' | Oth insomnia not due to a substance or known physiol cond |
'F5111' | Primary hypersomnia |
'F5112' | Insufficient sleep syndrome |
'F5113' | Hypersomnia due to other mental disorder |
'F5119' | Oth hypersomnia not due to a substance or known physiol cond |
'F513' | Sleepwalking [somnambulism] |
'F514' | Sleep terrors [night terrors] |
'F515' | Nightmare disorder |
'F518' | Oth sleep disord not due to a sub or known physiol cond |
'F519' | Sleep disorder not due to a sub or known physiol cond, unsp |
'F444' | Conversion disorder with motor symptom or deficit |
'F445' | Conversion disorder with seizures or convulsions |
'F446' | Conversion disorder with sensory symptom or deficit |
'F447' | Conversion disorder with mixed symptom presentation |
'F450' | Somatization disorder |
'F451' | Undifferentiated somatoform disorder |
'F4520' | Hypochondriacal disorder, unspecified |
'F4529' | Other hypochondriacal disorders |
'F4541' | Pain disorder exclusively related to psychological factors |
'F4542' | Pain disorder with related psychological factors |
'F458' | Other somatoform disorders |
'F459' | Somatoform disorder, unspecified/td> |
'F54' | Psych & behavrl factors assoc w disord or dis classd elswhr |
'F6810' | Factitious disorder, unspecified |
'R45851' | Suicidal ideations |
'T1491' | Suicide attempt (through FY 2017) |
'T1491XA' | Suicide attempt, initial encounter |
'T360X2A' | Poisoning by penicillins, intentional self-harm, init encntr |
'T361X2A' | Poisn by cephalospor/oth beta-lactm antibiot, slf-hrm, init |
'T362X2A' | Poisoning by chloramphenicol group, self-harm, init |
'T363X2A' | Poisoning by macrolides, intentional self-harm, init encntr |
'T364X2A' | Poisoning by tetracyclines, intentional self-harm, init |
'T365X2A' | Poisoning by aminoglycosides, intentional self-harm, init |
'T366X2A' | Poisoning by rifampicins, intentional self-harm, init encntr |
'T367X2A' | Poisoning by antifungal antibiot, sys used, self-harm, init |
'T368X2A' | Poisoning by oth systemic antibiotics, self-harm, init |
'T3692XA' | Poisoning by unsp systemic antibiotic, self-harm, init |
'T370X2A' | Poisoning by sulfonamides, intentional self-harm, init |
'T371X2A' | Poisoning by antimycobacterial drugs, self-harm, init |
'T372X2A' | Poisn by antimalari/drugs act on bld protzoa, slf-hrm, init |
'T373X2A' | Poisoning by oth antiprotozoal drugs, self-harm, init |
'T374X2A' | Poisoning by anthelminthics, intentional self-harm, init |
'T375X2A' | Poisoning by antiviral drugs, intentional self-harm, init |
'T378X2A' | Poisn by oth systemic anti-infect/parasit, self-harm, init |
'T3792XA' | Poisn by unsp sys anti-infect and antiparastc, slf-hrm, init |
'T380X2A' | Poisoning by glucocort/synth analog, self-harm, init |
'T381X2A' | Poisoning by thyroid hormones and sub, self-harm, init |
'T382X2A' | Poisoning by antithyroid drugs, intentional self-harm, init |
'T383X2A' | Poisn by insulin and oral hypoglycemic drugs, slf-hrm, init |
'T384X2A' | Poisoning by oral contraceptives, self-harm, init |
'T385X2A' | Poisoning by oth estrogens and progestogens, self-harm, init |
'T386X2A' | Poisn by antigonadtr/antiestr/antiandrg, NEC, slf-hrm, init |
'T387X2A' | Poisn by androgens and anabolic congeners, self-harm, init |
'T38802A' | Poisn by unsp hormones and synthetic sub, self-harm, init |
'T38812A' | Poisoning by anterior pituitary hormones, self-harm, init |
'T38892A' | Poisoning by oth hormones and synthetic sub, self-harm, init |
'T38902A' | Poisoning by unsp hormone antagonists, self-harm, init |
'T38992A' | Poisoning by oth hormone antagonists, self-harm, init |
'T39012A' | Poisoning by aspirin, intentional self-harm, init encntr |
'T39092A' | Poisoning by salicylates, intentional self-harm, init encntr |
'T391X2A' | Poisoning by 4-Aminophenol derivatives, self-harm, init |
'T392X2A' | Poisoning by pyrazolone derivatives, self-harm, init |
'T39312A' | Poisoning by propionic acid derivatives, self-harm, init |
'T39392A' | Poisn by oth nonsteroid anti-inflam drugs, self-harm, init |
'T394X2A' | Poisoning by antirheumatics, NEC, self-harm, init |
'T398X2A' | Poisn by oth nonopio analges/antipyret, NEC, self-harm, init |
'T3992XA' | Poisn by unsp nonopi analgs/antipyr/antirheu, slf-hrm, init |
'T405X2A' | Poisoning by cocaine, intentional self-harm, init encntr |
'T407X2A' | Poisoning by cannabis (derivatives), self-harm, init |
'T408X2A' | Poisoning by lysergide, intentional self-harm, init encntr |
'T40902A' | oisoning by unsp psychodysleptics, self-harm, init |
'T40992A' | Poisoning by oth psychodysleptics, self-harm, init |
'T410X2A' | Poisoning by inhaled anesthetics, self-harm, init |
'T411X2A' | Poisoning by intravenous anesthetics, self-harm, init |
'T41202A' | Poisoning by unsp general anesthetics, self-harm, init |
'T41292A' | Poisoning by oth general anesthetics, self-harm, init |
'T413X2A' | Poisoning by local anesthetics, intentional self-harm, init |
'T4142XA' | Poisoning by unsp anesthetic, intentional self-harm, init |
'T415X2A' | Poisoning by therapeutic gases, intentional self-harm, init |
'T420X2A' | Poisoning by hydantoin derivatives, self-harm, init |
'T421X2A' | Poisoning by iminostilbenes, intentional self-harm, init |
'T422X2A' | Poisn by succinimides and oxazolidinediones, self-harm, init |
'T423X2A' | Poisoning by barbiturates, intentional self-harm, init |
'T424X2A' | Poisoning by benzodiazepines, intentional self-harm, init |
'T425X2A' | Poisoning by mixed antiepileptics, self-harm, init |
'T426X2A' | Poisn by oth antieplptc and sed-hypntc drugs, slf-hrm, init |
'T4272XA' | Poisn by unsp antieplptc and sed-hypntc drugs, slf-hrm, init |
'T428X2A' | Poisn by antiparkns drug/centr musc-tone depr, slf-hrm, init |
'T43012A' | Poisoning by tricyclic antidepressants, self-harm, init |
'T43022A' | Poisoning by tetracyclic antidepressants, self-harm, init |
'T431X2A' | Poisoning by MAO inhib antidepressants, self-harm, init |
'T43202A' | Poisoning by unsp antidepressants, self-harm, init |
'T43212A' | Poisn by slctv seroton/norepineph reup inhibtr,slf-hrm, init |
'T43222A' | Poisn by slctv serotonin reuptake inhibtr, self-harm, init |
'T43292A' | Poisoning by oth antidepressants, self-harm, init |
'T433X2A' | Poisn by phenothiaz antipsychot/neurolept, self-harm, init |
'T434X2A' | Poisn by butyrophen/thiothixen neuroleptc, self-harm, init |
'T43502A' | Poisoning by unsp antipsychot/neurolept, self-harm, init |
'T43592A' | Poisoning by oth antipsychot/neurolept, self-harm, init |
'T43602A' | Poisoning by unsp psychostimulants, self-harm, init |
'T43612A' | Poisoning by caffeine, intentional self-harm, init encntr |
'T43622A' | Poisoning by amphetamines, intentional self-harm, init |
'T43632A' | Poisoning by methylphenidate, intentional self-harm, init |
'T43692A' | Poisoning by oth psychostimulants, self-harm, init |
'T438X2A' | Poisoning by oth psychotropic drugs, self-harm, init |
'T4392XA' | Poisoning by unsp psychotropic drug, self-harm, init |
'T440X2A' | Poisoning by anticholinesterase agents, self-harm, init |
'T441X2A' | Poisoning by oth parasympathomimetics, self-harm, init |
'T442X2A' | Poisoning by ganglionic blocking drugs, self-harm, init |
'T443X2A' | Poisn by oth parasympath and spasmolytics, self-harm, init |
'T444X2A' | Poisn by predom alpha-adrenocpt agonists, self-harm, init |
'T445X2A' | Poisoning by predom beta-adrenocpt agonists, self-harm, init |
'T446X2A' | Poisoning by alpha-adrenocpt antagonists, self-harm, init |
'T447X2A' | Poisoning by beta-adrenocpt antagonists, self-harm, init |
'T448X2A' | Poisn by centr-acting/adren-neurn-block agnt, slf-hrm, init |
'T44902A' | Poisn by unsp drugs aff the autonm nrv sys, slf-hrm, init |
'T44992A' | Poisn by oth drug aff the autonm nervous sys, slf-hrm, init |
'T450X2A' | Poisoning by antiallerg/antiemetic, self-harm, init |
'T451X2A' | Poisoning by antineopl and immunosup drugs, self-harm, init |
'T452X2A' | Poisoning by vitamins, intentional self-harm, init encntr |
'T453X2A' | Poisoning by enzymes, intentional self-harm, init encntr |
'T454X2A' | Poisoning by iron and its compounds, self-harm, init |
'T45512A' | Poisoning by anticoagulants, intentional self-harm, init |
'T45522A' | Poisoning by antithrombotic drugs, self-harm, init |
'T45602A' | Poisoning by unsp fibrin-affct drugs, self-harm, init |
'T45612A' | Poisoning by thrombolytic drug, intentional self-harm, init |
'T45622A' | Poisoning by hemostatic drug, intentional self-harm, init |
'T45692A' | Poisoning by oth fibrin-affct drugs, self-harm, init |
'T457X2A' | Poisn by anticoag antag, vit K and oth coag, slf-hrm, init |
'T458X2A' | Poisn by oth prim sys and hematolog agents, slf-hrm, init |
'T4592XA' | Poisn by unsp prim sys and hematolog agent, slf-hrm, init |
'T460X2A' | Poisn by cardi-stim glycos/drug simlar act, self-harm, init |
'T461X2A' | Poisoning by calcium-channel blockers, self-harm, init |
'T462X2A' | Poisoning by oth antidysrhythmic drugs, self-harm, init |
'T463X2A' | Poisoning by coronary vasodilators, self-harm, init |
'T464X2A' | Poisn by angiotens-convert-enzyme inhibtr, self-harm, init |
'T465X2A' | Poisoning by oth antihypertensive drugs, self-harm, init |
'T466X2A' | Poisn by antihyperlip and antiarterio drugs, self-harm, init |
'T467X2A' | Poisoning by peripheral vasodilators, self-harm, init |
'T468X2A' | Poisn by antivaric drugs, inc scler agents, self-harm, init |
'T46902A' | Poisn by unsp agents aff the cardiovasc sys, self-harm, init |
'T46992A' | Poisn by oth agents aff the cardiovasc sys, self-harm, init |
'T470X2A' | Poisoning by histamine H2-receptor blockers, self-harm, init |
'T471X2A' | Poisn by oth antacids & anti-gstrc-sec drugs, slf-hrm, init |
'T472X2A' | Poisoning by stimulant laxatives, self-harm, init |
'T473X2A' | Poisoning by saline and osmotic laxatives, self-harm, init |
'T474X2A' | Poisoning by oth laxatives, intentional self-harm, init |
'T475X2A' | Poisoning by digestants, intentional self-harm, init encntr |
'T476X2A' | Poisoning by antidiarrheal drugs, self-harm, init |
'T477X2A' | Poisoning by emetics, intentional self-harm, init encntr |
'T478X2A' | Poisoning by oth agents aff GI sys, self-harm, init |
'T4792XA' | Poisoning by unsp agents aff the GI sys, self-harm, init |
'T480X2A' | Poisoning by oxytocic drugs, intentional self-harm, init |
'T481X2A' | Poisoning by skeletal muscle relaxants, self-harm, init |
'T48202A' | Poisoning by unsp drugs acting on muscles, self-harm, init |
'T48292A' | Poisoning by oth drugs acting on muscles, self-harm, init |
'T483X2A' | Poisoning by antitussives, intentional self-harm, init |
'T484X2A' | Poisoning by expectorants, intentional self-harm, init |
'T485X2A' | Poisoning by oth anti-common-cold drugs, self-harm, init |
'T486X2A' | Poisoning by antiasthmatics, intentional self-harm, init |
'T48902A' | Poisn by unsp agents prim act on the resp sys, slf-hrm, init |
'T48992A' | Poisn by oth agents prim act on the resp sys, slf-hrm, init |
'T490X2A' | Poisn by local antifung/infect/inflamm drugs, slf-hrm, init |
'T491X2A' | Poisoning by antipruritics, intentional self-harm, init |
'T492X2A' | Poisoning by local astringents/detergents, self-harm, init |
'T493X2A' | Poisn by emollients, demulcents and protect, self-harm, init |
'T494X2A' | Poisn by keratolyt/keratplst/hair trmt drug, self-harm, init |
'T495X2A' | Poisoning by opth drugs and preparations, self-harm, init |
'T496X2A' | Poisoning by otorhino drugs and prep, self-harm, init |
'T497X2A' | Poisn by dental drugs, topically applied, self-harm, init |
'T498X2A' | Poisoning by oth topical agents, intentional self-harm, init |
'T4992XA' | Poisoning by unsp topical agent, intentional self-harm, init |
'T500X2A' | Poisoning by mineralocorticoids and antag, self-harm, init |
'T501X2A' | Poisoning by loop diuretics, intentional self-harm, init |
'T502X2A' | Poisn by crbnc-anhydr inhibtr,benzo/oth diuretc,slf-hrm,init |
'T503X2A' | Poisn by electrolytic/caloric/wtr-bal agnt, self-harm, init |
'T504X2A' | Poisoning by drugs aff uric acid metab, self-harm, init |
'T505X2A' | Poisoning by appetite depressants, self-harm, init |
'T506X2A' | Poisoning by antidotes and chelating agents, self-harm, init |
'T507X2A' | Poisn by analeptics and opioid receptor antag, slf-hrm, init |
'T508X2A' | Poisoning by diagnostic agents, intentional self-harm, init |
'T50902A' | Poisoning by unsp drug/meds/biol subst, self-harm, init |
'T50992A' | Poisoning by oth drug/meds/biol subst, self-harm, init |
'T50A12A' | Poisn by pertuss vaccn, inc combin w pertuss, slf-hrm, init |
'T50A22A' | Poisn by mixed bact vaccines w/o a pertuss, self-harm, init |
'T50A92A' | Poisoning by oth bacterial vaccines, self-harm, init |
'T50B12A' | Poisoning by smallpox vaccines, intentional self-harm, init |
'T50B92A' | Poisoning by oth viral vaccines, intentional self-harm, init |
'T50Z12A' | Poisoning by immunoglobulin, intentional self-harm, init |
'T50Z92A' | Poisoning by oth vaccines and biolg substnc, self-harm, init |
'T510X2A' | Toxic effect of ethanol, intentional self-harm, init encntr |
'T511X2A' | Toxic effect of methanol, intentional self-harm, init encntr |
'T512X2A' | Toxic effect of 2-Propanol, intentional self-harm, init |
'T513X2A' | Toxic effect of fusel oil, intentional self-harm, init |
'T518X2A' | Toxic effect of oth alcohols, intentional self-harm, init |
'T5192XA' | Toxic effect of unsp alcohol, intentional self-harm, init |
'T520X2A' | Toxic effect of petroleum products, self-harm, init |
'T521X2A' | Toxic effect of benzene, intentional self-harm, init encntr |
'T522X2A' | Toxic effect of homologues of benzene, self-harm, init |
'T523X2A' | Toxic effect of glycols, intentional self-harm, init encntr |
'T524X2A' | Toxic effect of ketones, intentional self-harm, init encntr |
'T528X2A' | Toxic effect of organic solvents, self-harm, init |
'T5292XA' | Toxic effect of unsp organic solvent, self-harm, init |
'T530X2A' | Toxic effect of carbon tetrachloride, self-harm, init |
'T531X2A' | Toxic effect of chloroform, intentional self-harm, init |
'T532X2A' | Toxic effect of trichloroethylene, self-harm, init |
'T533X2A' | Toxic effect of tetrachloroethylene, self-harm, init |
'T534X2A' | Toxic effect of dichloromethane, intentional self-harm, init |
'T535X2A' | Toxic effect of chlorofluorocarbons, self-harm, init |
'T536X2A' | Tox eff of halgn deriv of aliphatic hydrocrb, slf-hrm, init |
'T537X2A' | Toxic eff of halgn deriv of aromatic hydrocrb, slf-hrm, init |
'T5392XA' | Tox eff of unsp halgn deriv of aromat hydrocrb,slf-hrm, init |
'T540X2A' | Toxic effect of phenol and phenol homolog, self-harm, init |
'T541X2A' | Toxic effect of corrosive organic compounds, self-harm, init |
'T542X2A' | Tox eff of corrosv acids & acid-like substnc, slf-hrm, init |
'T543X2A' | Tox eff of corrosv alkalis & alk-like substnc, slf-hrm, init |
'T5492XA' | Toxic effect of unsp corrosive substance, self-harm, init |
'T550X2A' | Toxic effect of soaps, intentional self-harm, init encntr |
'T551X2A' | Toxic effect of detergents, intentional self-harm, init |
'T560X2A' | Toxic effect of lead and its compounds, self-harm, init |
'T561X2A' | Toxic effect of mercury and its compounds, self-harm, init |
'T562X2A' | Toxic effect of chromium and its compounds, self-harm, init |
'T563X2A' | Toxic effect of cadmium and its compounds, self-harm, init |
'T564X2A' | Toxic effect of copper and its compounds, self-harm, init |
'T565X2A' | Toxic effect of zinc and its compounds, self-harm, init |
'T566X2A' | Toxic of tin and its compounds, self-harm, init |
'T567X2A' | Toxic effect of beryllium and its compounds, self-harm, init |
'T56812A' | Toxic effect of thallium, intentional self-harm, init encntr |
'T56892A' | Toxic effect of oth metals, intentional self-harm, init |
'T5692XA' | Toxic effect of unsp metal, intentional self-harm, init |
'T570X2A' | Toxic effect of arsenic and its compounds, self-harm, init |
'T571X2A' | Toxic effect of phosphorus and its compnd, self-harm, init |
'T572X2A' | Toxic effect of manganese and its compounds, self-harm, init |
'T573X2A' | Toxic of hydrogen cyanide, self-harm, init |
'T578X2A' | Toxic effect of inorganic substances, self-harm, init |
'T5792XA' | Toxic effect of unsp inorganic substance, self-harm, init |
'T5802XA' | Toxic eff of carb monx from mtr veh exhaust, slf-hrm, init |
'T5812XA' | Toxic effect of carb monx from utility gas, self-harm, init |
'T582X2A' | Tox eff of carb monx fr incmpl combst dmst fuel,slf-hrm,init |
'T588X2A' | Toxic effect of carb monx from oth source, self-harm, init |
'T5892XA' | Toxic effect of carb monx from unsp source, self-harm, init |
'T590X2A' | Toxic effect of nitrogen oxides, intentional self-harm, init |
'T591X2A' | Toxic effect of sulfur dioxide, intentional self-harm, init |
'T592X2A' | Toxic effect of formaldehyde, intentional self-harm, init |
'T593X2A' | Toxic effect of lacrimogenic gas, self-harm, init |
'T594X2A' | Toxic of chlorine gas, intentional self-harm, init |
'T595X2A' | Tox eff of fluorine gas and hydrogen fluoride, slf-hrm, init |
'T596X2A' | Toxic effect of hydrogen sulfide, self-harm, init |
'T597X2A' | Toxic effect of carbon dioxide, intentional self-harm, init |
'T59812A' | Toxic effect of smoke, intentional self-harm, init encntr |
'T59892A' | Toxic effect of gases, fumes and vapors, self-harm, init |
'T5992XA' | Toxic effect of unsp gases, fumes and vapors, slf-hrm, init |
'T600X2A' | Toxic eff of organophos and carbamate insect, slf-hrm, init |
'T601X2A' | Toxic effect of halogenated insecticides, self-harm, init |
'T602X2A' | Toxic effect of insecticides, intentional self-harm, init |
'T603X2A' | Toxic effect of herbicides and fungicides, self-harm, init |
'T604X2A' | Toxic effect of rodenticides, intentional self-harm, init |
'T608X2A' | Toxic effect of oth pesticides, intentional self-harm, init |
'T6092XA' | Toxic effect of unsp pesticide, intentional self-harm, init |
'T6102XA' | Ciguatera fish poisoning, intentional self-harm, init encntr |
'T6112XA' | Scombroid fish poisoning, intentional self-harm, init encntr |
'T61772A' | Other fish poisoning, intentional self-harm, init encntr |
'T61782A' | Oth shellfish poisoning, intentional self-harm, init encntr |
'T618X2A' | Toxic effect of oth seafood, intentional self-harm, init |
'T6192XA' | Toxic effect of unsp seafood, intentional self-harm, init |
'T620X2A' | Toxic effect of ingested mushrooms, self-harm, init |
'T621X2A' | Toxic effect of ingested berries, self-harm, init |
'T622X2A' | Toxic effect of ingested (parts of) plant(s), slf-hrm, init |
'T628X2A' | Toxic effect of noxious substnc eaten as food, slf-hrm, init |
'T6292XA' | Toxic eff of unsp noxious sub eaten as food, slf-hrm, init |
'T63002A' | Toxic effect of unsp snake venom, self-harm, init |
'T63012A' | Toxic effect of rattlesnake venom, self-harm, init |
'T63022A' | Toxic effect of coral snake venom, self-harm, init |
'T63032A' | Toxic effect of taipan venom, intentional self-harm, init |
'T63042A' | Toxic effect of cobra venom, intentional self-harm, init |
'T63062A' | Toxic effect of venom of N & S American snake, slf-hrm, init |
'T63072A' | Toxic effect of venom of Australian snake, self-harm, init |
'T63082A' | Toxic eff of venom of African and Asian snake, slf-hrm, init |
'T63092A' | Toxic effect of venom of snake, intentional self-harm, init |
'T63112A' | Toxic effect of venom of gila monster, self-harm, init |
'T63122A' | Toxic effect of venom of venomous lizard, self-harm, init |
'T63192A' | Toxic effect of venom of reptiles, self-harm, init |
'T632X2A' | Toxic of venom of scorpion, self-harm, init |
'T63302A' | Toxic effect of unsp spider venom, self-harm, init |
'T63312A' | Toxic effect of venom of black widow spider, self-harm, init |
'T63322A' | Toxic effect of venom of tarantula, self-harm, init |
'T63332A' | Toxic effect of venom of brown recluse spider, slf-hrm, init |
'T63392A' | Toxic effect of venom of spider, intentional self-harm, init |
'T63412A' | Toxic effect of venom of centipede/millipede, slf-hrm, init |
'T63422A' | Toxic effect of venom of ants, intentional self-harm, init |
'T63432A' | Toxic effect of venom of caterpillars, self-harm, init |
'T63442A' | Toxic effect of venom of bees, intentional self-harm, init |
'T63452A' | Toxic effect of venom of hornets, self-harm, init |
'T63462A' | Toxic effect of venom of wasps, intentional self-harm, init |
'T63482A' | Toxic effect of venom of arthropod, self-harm, init |
'T63512A' | Toxic effect of contact w stingray, self-harm, init |
'T63592A' | Toxic effect of contact w oth venomous fish, self-harm, init |
'T63612A' | Toxic effect of contact w Portugese Man-o-war, slf-hrm, init |
'T63622A' | Toxic effect of contact w oth jellyfish, self-harm, init |
'T63632A' | Toxic effect of contact w sea anemone, self-harm, init |
'T63692A' | Toxic eff of cntct w oth venom marine animals, slf-hrm, init |
'T63712A' | Toxic effect of contact w venom marine plant, slf-hrm, init |
'T63792A' | Toxic effect of contact w oth venomous plant, slf-hrm, init |
'T63812A' | Toxic effect of contact w venomous frog, self-harm, init |
'T63822A' | Toxic effect of contact w venomous toad, self-harm, init |
'T63832A' | Toxic effect of contact w oth venomous amphib, slf-hrm, init |
'T63892A' | Toxic effect of contact w oth venom animals, slf-hrm, init |
'T6392XA' | Toxic effect of w unsp venom animal, slf-hrm, init |
'T6402XA' | Toxic effect of aflatoxin, intentional self-harm, init |
'T6482XA' | Toxic effect of mycotoxin food contaminants, self-harm, init |
'T650X2A' | Toxic effect of cyanides, intentional self-harm, init encntr |
'T651X2A' | Toxic effect of strychnine and its salts, self-harm, init |
'T65212A' | Toxic effect of chewing tobacco, intentional self-harm, init |
'T65222A' | Toxic effect of tobacco cigarettes, self-harm, init |
'T65292A' | Toxic effect of tobacco and nicotine, self-harm, init |
'T653X2A' | Tox eff of nitrodrv/aminodrv of benzn/homolog, slf-hrm, init |
'T654X2A' | Toxic effect of carbon disulfide, self-harm, init |
'T655X2A' | Tox eff of nitro & oth nitric acids & esters, slf-hrm, init |
'T656X2A' | Toxic effect of paints and dyes, NEC, self-harm, init |
'T65812A' | Toxic effect of latex, intentional self-harm, init encntr |
'T65822A' | Toxic eff of harmful algae and algae toxins, slf-hrm, init |
'T65832A' | Toxic effect of fiberglass, intentional self-harm, init |
'T65892A' | Toxic effect of oth substances, intentional self-harm, init |
'T6592XA' | Toxic effect of unsp substance, intentional self-harm, init |
'T71112A' | Asphyxiation due to smothering under pillow, self-harm, init |
'T71122A' | Asphyxiation due to plastic bag, intentional self-harm, init |
'T71132A' | Asphyx due to being trapped in bed linens, self-harm, init |
'T71152A' | Asphyxiation due to smothering in furniture, self-harm, init |
'T71162A' | Asphyxiation due to hanging, intentional self-harm, init |
'T71192A' | Asphyx d/t mech thrt to breathe d/t oth cause, slf-hrm, init |
'T71222A' | Asphyx due to being trapped in a car trunk, self-harm, init |
'T71232A' | Asphyx d/t being trap in a (discarded) refrig, slf-hrm, init |
'X710XXA' | Intentional self-harm by drown while in bathtub, init |
'X711XXA' | Intentional self-harm by drown while in swimming pool, init |
'X712XXA' | Self-harm by drown after jump into swimming pool, init |
'X713XXA' | Intentional self-harm by drown in natural water, init |
'X718XXA' | Oth intentional self-harm by drowning and submersion, init |
'X719XXA' | Intentional self-harm by drowning and submersion, unsp, init |
'X72XXXA' | Intentional self-harm by handgun discharge, init encntr |
'X730XXA' | Intentional self-harm by shotgun discharge, init encntr |
'X731XXA' | Intentional self-harm by hunting rifle discharge, init |
'X732XXA' | Intentional self-harm by machine gun discharge, init encntr |
'X738XXA' | Intentional self-harm by oth larger firearm discharge, init |
'X739XXA' | Intentional self-harm by unsp larger firearm discharge, init |
'X7401XA' | Intentional self-harm by airgun, initial encounter |
'X7402XA' | Intentional self-harm by paintball gun, initial encounter |
'X7409XA' | Self-harm by oth gas, air or spring-operated gun, init |
'X748XXA' | Intentional self-harm by oth firearm discharge, init encntr |
'X749XXA' | Intentional self-harm by unsp firearm discharge, init encntr |
'X75XXXA' | Intentional self-harm by explosive material, init encntr |
'X76XXXA' | Intentional self-harm by smoke, fire and flames, init encntr |
'X770XXA' | Intentional self-harm by steam or hot vapors, init encntr |
'X771XXA' | Intentional self-harm by hot tap water, initial encounter |
'X772XXA' | Intentional self-harm by other hot fluids, initial encounter |
'X773XXA' | Intentional self-harm by hot household appliances, init |
'X778XXA' | Intentional self-harm by other hot objects, init encntr |
'X779XXA' | Intentional self-harm by unsp hot objects, init encntr |
'X780XXA' | Intentional self-harm by sharp glass, initial encounter |
'X781XXA' | Intentional self-harm by knife, initial encounter |
'X782XXA' | Intentional self-harm by sword or dagger, initial encounter |
'X788XXA' | Intentional self-harm by sharp object, init encntr |
'X789XXA' | Intentional self-harm by unsp sharp object, init encntr |
'X79XXXA' | Intentional self-harm by blunt object, initial encounter |
'X80XXXA' | Intentional self-harm by jumping from a high place, init |
'X810XXA' | Self-harm by jumping or lying in front of mtr veh, init |
'X811XXA' | Slf-hrm by jumping or lying in front of (subway) train, init |
'X818XXA' | Slf-hrm by jumping or lying in front of moving object, init |
'X820XXA' | Intentional collision of motor vehicle w mtr veh, init |
'X821XXA' | Intentional collision of motor vehicle w train, init encntr |
'X822XXA' | Intentional collision of motor vehicle w tree, init encntr |
'X828XXA' | Oth intentional self-harm by crashing of motor vehicle, init |
'X830XXA' | Intentional self-harm by crashing of aircraft, init encntr |
'X831XXA' | Intentional self-harm by electrocution, initial encounter |
'X832XXA' | Intentional self-harm by exposure to extremes of cold, init |
'X838XXA' | Intentional self-harm by other specified means, init encntr |
'F59' | Unsp behavrl synd assoc w physiol disturb and physcl factors |
'F988' | Oth behav/emotn disord w onset usly occur in chldhd and adol |
'F989' | Unsp behav/emotn w onst usly occur in chldhd and adol |
'R452' | Unhappiness |
'R453' | Demoralization and apathy |
'R454' | Irritability and anger |
'R455' | Hostility |
'R456' | Violent behavior |
'R457' | State of emotional shock and stress, unspecified |
'R4581' | Low self-esteem |
'R4582' | Worries |
'R4583' | Excessive crying of child, adolescent or adult |
'R4584' | Anhedonia |
'R4586' | Emotional lability |
'R4589' | Other symptoms and signs involving emotional state |
'R460' | Very low level of personal hygiene |
'R461' | Bizarre personal appearance |
'R462' | Strange and inexplicable behavior |
'R463' | Overactivity |
'R464' | Slowness and poor responsiveness |
'R465' | Suspiciousness and marked evasiveness |
'R467' | Verbosity and circumstantial detail obscuring rsn for cntct |
'R4689' | Other symptoms and signs involving appearance and behavior |
'F430' | Acute stress reaction |
'F4310' | Post-traumatic stress disorder, unspecified |
'F4320' | Adjustment disorder, unspecified |
'F4321' | Adjustment disorder with depressed mood |
'F4322' | Adjustment disorder with anxiety |
'F4323' | Adjustment disorder with mixed anxiety and depressed mood |
'F4324' | Adjustment disorder with disturbance of conduct |
'F4325' | Adjustment disorder w mixed disturb of emotions and conduct |
'F4329' | Adjustment disorder with other symptoms |
'F438' | Other reactions to severe stress |
'F439' | Reaction to severe stress, unspecified |
'F941' | Reactive attachment disorder of childhood |
'F942' | Disinhibited attachment disorder of childhood |
Table B-2: Substance Use ICD-10-CMS Diagnosis Codes |
ICD-10-CM DIAGNOSIS | DESCRIPTION |
---|---|
'F1010' | Alcohol abuse, uncomplicated |
'F10120' | Alcohol abuse with intoxication, uncomplicated |
'F10121' | Alcohol abuse with intoxication delirium |
'F10129' | Alcohol abuse with intoxication, unspecified |
'F1014' | Alcohol abuse with alcohol-induced mood disorder |
'F10150' | Alcohol abuse w alcoh-induce psychotic disorder w delusions |
'F10151' | Alcohol abuse w alcoh-induce psychotic disorder w hallucin |
'F10159' | Alcohol abuse with alcohol-induced psychotic disorder, unsp |
'F10180' | Alcohol abuse with alcohol-induced anxiety disorder |
'F10181' | Alcohol abuse with alcohol-induced sexual dysfunction |
'F10182' | Alcohol abuse with alcohol-induced sleep disorder |
'F10188' | Alcohol abuse with other alcohol-induced disorder |
'F1019' | Alcohol abuse with unspecified alcohol-induced disorder |
'F1020' | Alcohol dependence, uncomplicated |
'F10220' | Alcohol dependence with intoxication, uncomplicated |
'F10221' | Alcohol dependence with intoxication delirium |
'F10229' | Alcohol dependence with intoxication, unspecified |
'F10230' | Alcohol dependence with withdrawal, uncomplicated |
'F10231' | Alcohol dependence with withdrawal delirium |
'F10232' | Alcohol dependence w withdrawal with perceptual disturbance |
'F10239' | Alcohol dependence with withdrawal, unspecified |
'F1024' | Alcohol dependence with alcohol-induced mood disorder |
'F10250' | Alcohol depend w alcoh-induce psychotic disorder w delusions |
'F10251' | Alcohol depend w alcoh-induce psychotic disorder w hallucin |
'F10259' | Alcohol dependence w alcoh-induce psychotic disorder, unsp |
'F1026' | Alcohol depend w alcoh-induce persisting amnestic disorder |
'F1027' | Alcohol dependence with alcohol-induced persisting dementia |
'F10280' | Alcohol dependence with alcohol-induced anxiety disorder |
'F10281' | Alcohol dependence with alcohol-induced sexual dysfunction |
'F10282' | Alcohol dependence with alcohol-induced sleep disorder |
'F10288' | Alcohol dependence with other alcohol-induced disorder |
'F1029' | Alcohol dependence with unspecified alcohol-induced disorder |
'F10920' | Alcohol use, unspecified with intoxication, uncomplicated |
'F10921' | Alcohol use, unspecified with intoxication delirium |
'F10929' | Alcohol use, unspecified with intoxication, unspecified |
'F1094' | Alcohol use, unspecified with alcohol-induced mood disorder |
'F10950' | Alcohol use, unsp w alcoh-induce psych disorder w delusions |
'F10951' | Alcohol use, unsp w alcoh-induce psych disorder w hallucin |
'F10959' | Alcohol use, unsp w alcohol-induced psychotic disorder, unsp |
'F1096' | Alcohol use, unsp w alcoh-induce persist amnestic disorder |
'F1097' | Alcohol use, unsp with alcohol-induced persisting dementia |
'F10980' | Alcohol use, unsp with alcohol-induced anxiety disorder |
'F10981' | Alcohol use, unsp with alcohol-induced sexual dysfunction |
'F10982' | Alcohol use, unspecified with alcohol-induced sleep disorder |
'F10988' | Alcohol use, unspecified with other alcohol-induced disorder |
'F1099' | Alcohol use, unsp with unspecified alcohol-induced disorder |
'G621' | Alcoholic polyneuropathy |
'I426' | Alcoholic cardiomyopathy |
'K2920' | Alcoholic gastritis without bleeding |
'K2921' | Alcoholic gastritis with bleeding |
'K700' | Alcoholic fatty liver |
'K7010' | Alcoholic hepatitis without ascites |
'K7011' | Alcoholic hepatitis with ascites |
'K702' | Alcoholic fibrosis and sclerosis of liver |
'K7030' | Alcoholic cirrhosis of liver without ascites |
'K7031' | Alcoholic cirrhosis of liver with ascites |
'K7040' | Alcoholic hepatic failure without coma |
'K709' | Alcoholic liver disease, unspecified |
'O99310' | Alcohol use complicating pregnancy, unspecified trimester |
'O99311' | Alcohol use complicating pregnancy, first trimester |
'O99312' | Alcohol use complicating pregnancy, second trimester |
'O99313' | Alcohol use complicating pregnancy, third trimester |
'O99314' | Alcohol use complicating childbirth |
'O99315' | Alcohol use complicating the puerperium |
'P043' | Newborn affected by maternal use of alcohol |
'Q860' | Fetal alcohol syndrome (dysmorphic) |
'F1210' | Cannabis abuse, uncomplicated |
'F12120' | Cannabis abuse with intoxication, uncomplicated |
'F12121' | Cannabis abuse with intoxication delirium |
'F12122' | Cannabis abuse with intoxication with perceptual disturbance |
'F12129' | Cannabis abuse with intoxication, unspecified |
'F12150' | Cannabis abuse with psychotic disorder with delusions |
'F12151' | Cannabis abuse with psychotic disorder with hallucinations |
'F12159' | Cannabis abuse with psychotic disorder, unspecified |
'F12180' | Cannabis abuse with cannabis-induced anxiety disorder |
'F12188' | Cannabis abuse with other cannabis-induced disorder |
'F1219' | Cannabis abuse with unspecified cannabis-induced disorder |
'F1220' | Cannabis dependence, uncomplicated |
'F12220' | Cannabis dependence with intoxication, uncomplicated |
'F12221' | Cannabis dependence with intoxication delirium |
'F12222' | Cannabis dependence w intoxication w perceptual disturbance |
'F12229' | Cannabis dependence with intoxication, unspecified |
'F12250' | Cannabis dependence with psychotic disorder with delusions |
'F12251' | Cannabis dependence w psychotic disorder with hallucinations |
'F12259' | Cannabis dependence with psychotic disorder, unspecified |
'F12280' | Cannabis dependence with cannabis-induced anxiety disorder |
'F12288' | Cannabis dependence with other cannabis-induced disorder |
'F1229' | Cannabis dependence with unsp cannabis-induced disorder |
'F1290' | Cannabis use, unspecified, uncomplicated |
'F12920' | Cannabis use, unspecified with intoxication, uncomplicated |
'F12921' | Cannabis use, unspecified with intoxication delirium |
'F12922' | Cannabis use, unsp w intoxication w perceptual disturbance |
'F12929' | Cannabis use, unspecified with intoxication, unspecified |
'F12950' | Cannabis use, unsp with psychotic disorder with delusions |
'F12951' | Cannabis use, unsp w psychotic disorder with hallucinations |
'F12959' | Cannabis use, unsp with psychotic disorder, unspecified |
'F12980' | Cannabis use, unspecified with anxiety disorder |
'F12988' | Cannabis use, unsp with other cannabis-induced disorder |
'F1299' | Cannabis use, unsp with unsp cannabis-induced disorder |
'T407X1A' | Poisoning by cannabis (derivatives), accidental, init |
'T407X3A' | Poisoning by cannabis (derivatives), assault, init encntr |
'T407X4A' | Poisoning by cannabis (derivatives), undetermined, init |
'T407X5A' | Adverse effect of cannabis (derivatives), initial encounter |
'F1610' | Hallucinogen abuse, uncomplicated |
'F16120' | Hallucinogen abuse with intoxication, uncomplicated |
'F16121' | Hallucinogen abuse with intoxication with delirium |
'F16122' | Hallucinogen abuse w intoxication w perceptual disturbance |
'F16129' | Hallucinogen abuse with intoxication, unspecified |
'F1614' | Hallucinogen abuse with hallucinogen-induced mood disorder |
'F16150' | Hallucinogen abuse w psychotic disorder w delusions |
'F16151' | Hallucinogen abuse w psychotic disorder w hallucinations |
'F16159' | Hallucinogen abuse w psychotic disorder, unsp |
'F16180' | Hallucinogen abuse w hallucinogen-induced anxiety disorder |
'F16183' | Hallucign abuse w hallucign persisting perception disorder |
'F16188' | Hallucinogen abuse with other hallucinogen-induced disorder |
'F1619' | Hallucinogen abuse with unsp hallucinogen-induced disorder |
'F1620' | Hallucinogen dependence, uncomplicated |
'F16220' | Hallucinogen dependence with intoxication, uncomplicated |
'F16221' | Hallucinogen dependence with intoxication with delirium |
'F16229' | Hallucinogen dependence with intoxication, unspecified |
'F1624' | Hallucinogen dependence w hallucinogen-induced mood disorder |
'F16250' | Hallucinogen dependence w psychotic disorder w delusions |
'F16251' | Hallucinogen dependence w psychotic disorder w hallucin |
'F16259' | Hallucinogen dependence w psychotic disorder, unsp |
'F16280' | Hallucinogen dependence w anxiety disorder |
'F16283' | Hallucign depend w hallucign persisting perception disorder |
'F16288' | Hallucinogen dependence w oth hallucinogen-induced disorder |
'F1629' | Hallucinogen dependence w unsp hallucinogen-induced disorder |
'F1690' | Hallucinogen use, unspecified, uncomplicated |
'F16920' | Hallucinogen use, unsp with intoxication, uncomplicated |
'F16921' | Hallucinogen use, unsp with intoxication with delirium |
'F16929' | Hallucinogen use, unspecified with intoxication, unspecified |
'F1694' | Hallucinogen use, unsp w hallucinogen-induced mood disorder |
'F16950' | Hallucinogen use, unsp w psychotic disorder w delusions |
'F16951' | Hallucinogen use, unsp w psychotic disorder w hallucinations |
'F16959' | Hallucinogen use, unsp w psychotic disorder, unsp |
'F16980' | Hallucinogen use, unsp w anxiety disorder |
'F16983' | Hallucign use, unsp w hallucign persist perception disorder |
'F16988' | Hallucinogen use, unsp w oth hallucinogen-induced disorder |
'F1699' | Hallucinogen use, unsp w unsp hallucinogen-induced disorder |
'T408X1A' | Poisoning by lysergide, accidental (unintentional), init |
'T408X3A' | Poisoning by lysergide [LSD], assault, initial encounter |
'T408X4A' | Poisoning by lysergide, undetermined, initial encounter |
'T408X5A' | Adverse effect of lysergide [LSD] initial encounter |
'T40901A' | Poisoning by unsp psychodyslept, accidental, init |
'T40903A' | Poisoning by unsp psychodysleptics, assault, init encntr |
'T40904A' | Poisoning by unsp psychodysleptics, undetermined, init |
'T40905A' | Adverse effect of unspecified psychodysleptics, init encntr |
'T40991A' | Poisoning by oth psychodyslept, accidental, init |
'T40993A' | Poisoning by other psychodysleptics, assault, init encntr |
'T40994A' | Poisoning by oth psychodysleptics, undetermined, init encntr |
'T40995A' | Adverse effect of other psychodysleptics, initial encounter |
'F1810' | Inhalant abuse, uncomplicated |
'F18120' | Inhalant abuse with intoxication, uncomplicated |
'F18121' | Inhalant abuse with intoxication delirium |
'F18129' | Inhalant abuse with intoxication, unspecified |
'F1814' | Inhalant abuse with inhalant-induced mood disorder |
'F18150' | Inhalant abuse w inhalnt-induce psych disorder w delusions |
'F18151' | Inhalant abuse w inhalnt-induce psych disorder w hallucin |
'F18159' | Inhalant abuse w inhalant-induced psychotic disorder, unsp |
'F1817' | Inhalant abuse with inhalant-induced dementia |
'F18180' | Inhalant abuse with inhalant-induced anxiety disorder |
'F18188' | Inhalant abuse with other inhalant-induced disorder |
'F1819' | Inhalant abuse with unspecified inhalant-induced disorder |
'F1820' | Inhalant dependence, uncomplicated |
'F18220' | Inhalant dependence with intoxication, uncomplicated |
'F18221' | Inhalant dependence with intoxication delirium |
'F18229' | Inhalant dependence with intoxication, unspecified |
'F1824' | Inhalant dependence with inhalant-induced mood disorder |
'F18250' | Inhalant depend w inhalnt-induce psych disorder w delusions |
'F18251' | Inhalant depend w inhalnt-induce psych disorder w hallucin |
'F18259' | Inhalant depend w inhalnt-induce psychotic disorder, unsp |
'F1827' | Inhalant dependence with inhalant-induced dementia |
'F18280' | Inhalant dependence with inhalant-induced anxiety disorder |
'F18288' | Inhalant dependence with other inhalant-induced disorder |
'F1829' | Inhalant dependence with unsp inhalant-induced disorder |
'F1890' | Inhalant use, unspecified, uncomplicated |
'F18920' | Inhalant use, unspecified with intoxication, uncomplicated |
'F18921' | Inhalant use, unspecified with intoxication with delirium |
'F18929' | Inhalant use, unspecified with intoxication, unspecified |
'F1894' | Inhalant use, unsp with inhalant-induced mood disorder |
'F18950' | Inhalant use, unsp w inhalnt-induce psych disord w delusions |
'F18951' | Inhalant use, unsp w inhalnt-induce psych disord w hallucin |
'F18959' | Inhalant use, unsp w inhalnt-induce psychotic disorder, unsp |
'F1897' | Inhalant use, unsp with inhalant-induced persisting dementia |
'F18980' | Inhalant use, unsp with inhalant-induced anxiety disorder |
'F18988' | Inhalant use, unsp with other inhalant-induced disorder |
'F1899' | Inhalant use, unsp with unsp inhalant-induced disorder |
'F1110' | Opioid abuse, uncomplicated |
'F11120' | Opioid abuse with intoxication, uncomplicated |
'F11121' | Opioid abuse with intoxication delirium |
'F11122' | Opioid abuse with intoxication with perceptual disturbance |
'F11129' | Opioid abuse with intoxication, unspecified |
'F1114' | Opioid abuse with opioid-induced mood disorder |
'F11150' | Opioid abuse w opioid-induced psychotic disorder w delusions |
'F11151' | Opioid abuse w opioid-induced psychotic disorder w hallucin |
'F11159' | Opioid abuse with opioid-induced psychotic disorder, unsp |
'F11181' | Opioid abuse with opioid-induced sexual dysfunction |
'F11182' | Opioid abuse with opioid-induced sleep disorder |
'F11188' | Opioid abuse with other opioid-induced disorder |
'F1119' | Opioid abuse with unspecified opioid-induced disorder |
'F1120' | Opioid dependence, uncomplicated |
'F11220' | Opioid dependence with intoxication, uncomplicated |
'F11221' | Opioid dependence with intoxication delirium |
'F11222' | Opioid dependence w intoxication with perceptual disturbance |
'F11229' | Opioid dependence with intoxication, unspecified |
'F1123' | Opioid dependence with withdrawal |
'F1124' | Opioid dependence with opioid-induced mood disorder |
'F11250' | Opioid depend w opioid-induc psychotic disorder w delusions |
'F11251' | Opioid depend w opioid-induc psychotic disorder w hallucin |
'F11259' | Opioid dependence w opioid-induced psychotic disorder, unsp |
'F11281' | Opioid dependence with opioid-induced sexual dysfunction |
'F11282' | Opioid dependence with opioid-induced sleep disorder |
'F11288' | Opioid dependence with other opioid-induced disorder |
'F1129' | Opioid dependence with unspecified opioid-induced disorder |
'F1190' | Opioid use, unspecified, uncomplicated |
'F11920' | Opioid use, unspecified with intoxication, uncomplicated |
'F11921' | Opioid use, unspecified with intoxication delirium |
'F11922' | Opioid use, unsp w intoxication with perceptual disturbance |
'F11929' | Opioid use, unspecified with intoxication, unspecified |
'F1193' | Opioid use, unspecified with withdrawal |
'F1194' | Opioid use, unspecified with opioid-induced mood disorder |
'F11950' | Opioid use, unsp w opioid-induc psych disorder w delusions |
'F11951' | Opioid use, unsp w opioid-induc psych disorder w hallucin |
'F11959' | Opioid use, unsp w opioid-induced psychotic disorder, unsp |
'F11981' | Opioid use, unsp with opioid-induced sexual dysfunction |
'F11982' | Opioid use, unspecified with opioid-induced sleep disorder |
'F11988' | Opioid use, unspecified with other opioid-induced disorder |
'F1199' | Opioid use, unsp with unspecified opioid-induced disorder |
'P961' | Neonatal w/drawal symp from matern use of drugs of addiction |
'T400X1A' | Poisoning by opium, accidental (unintentional), init encntr |
'T400X2A' | Poisoning by opium, intentional self-harm, initial encounter |
'T400X3A' | Poisoning by opium, assault, initial encounter |
'T400X4A' | Poisoning by opium, undetermined, initial encounter |
'T400X5A' | Adverse effect of opium, initial encounter |
'T401X1A' | Poisoning by heroin, accidental (unintentional), init encntr |
'T401X2A' | Poisoning by heroin, intentional self-harm, init encntr |
'T401X3A' | Poisoning by heroin, assault, initial encounter |
'T401X4A' | Poisoning by heroin, undetermined, initial encounter |
'T401X5A' | Adverse effect of heroin initial encounter |
'T402X2A' | Poisoning by oth opioids, intentional self-harm, init encntr |
'T403X2A' | Poisoning by methadone, intentional self-harm, init encntr |
'T404X2A' | Poisoning by oth synthetic narcotics, self-harm, init |
'T40602A' | Poisoning by unsp narcotics, intentional self-harm, init |
'T40692A' | Poisoning by oth narcotics, intentional self-harm, init |
'F1910' | Other psychoactive substance abuse, uncomplicated |
'F19120' | Oth psychoactive substance abuse w intoxication, uncomp |
'F19121' | Oth psychoactive substance abuse with intoxication delirium |
'F19122' | Oth psychoactv substance abuse w intox w perceptual disturb |
'F19129' | Other psychoactive substance abuse with intoxication, unsp |
'F1914' | Oth psychoactive substance abuse w mood disorder |
'F19150' | Oth psychoactv substance abuse w psych disorder w delusions |
'F19151' | Oth psychoactv substance abuse w psych disorder w hallucin |
'F19159' | Oth psychoactive substance abuse w psychotic disorder, unsp |
'F1916' | Oth psychoactv substance abuse w persist amnestic disorder |
'F1917' | Oth psychoactive substance abuse w persisting dementia |
'F19180' | Oth psychoactive substance abuse w anxiety disorder |
'F19181' | Oth psychoactive substance abuse w sexual dysfunction |
'F19182' | Oth psychoactive substance abuse w sleep disorder |
'F19188' | Oth psychoactive substance abuse w oth disorder |
'F1919' | Oth psychoactive substance abuse w unsp disorder |
'F1920' | Other psychoactive substance dependence, uncomplicated |
'F19220' | Oth psychoactive substance dependence w intoxication, uncomp |
'F19221' | Oth psychoactive substance dependence w intox delirium |
'F19222' | Oth psychoactv substance depend w intox w perceptual disturb |
'F19229' | Oth psychoactive substance dependence w intoxication, unsp |
'F19230' | Oth psychoactive substance dependence w withdrawal, uncomp |
'F19231' | Oth psychoactive substance dependence w withdrawal delirium |
'F19232' | Oth psychoactv sub depend w w/drawal w perceptl disturb |
'F19239' | Oth psychoactive substance dependence with withdrawal, unsp |
'F1924' | Oth psychoactive substance dependence w mood disorder |
'F19250' | Oth psychoactv substance depend w psych disorder w delusions |
'F19251' | Oth psychoactv substance depend w psych disorder w hallucin |
'F19259' | Oth psychoactv substance depend w psychotic disorder, unsp |
'F1926' | Oth psychoactv substance depend w persist amnestic disorder |
'F1927' | Oth psychoactive substance dependence w persisting dementia |
'F19280' | Oth psychoactive substance dependence w anxiety disorder |
'F19281' | Oth psychoactive substance dependence w sexual dysfunction |
'F19282' | Oth psychoactive substance dependence w sleep disorder |
'F19288' | Oth psychoactive substance dependence w oth disorder |
'F1929' | Oth psychoactive substance dependence w unsp disorder |
'F1990' | Other psychoactive substance use, unspecified, uncomplicated |
'F19920' | Oth psychoactive substance use, unsp w intoxication, uncomp |
'F19921' | Oth psychoactive substance use, unsp w intox w delirium |
'F19922' | Oth psychoactv sub use, unsp w intox w perceptl disturb |
'F19929' | Oth psychoactive substance use, unsp with intoxication, unsp |
'F19930' | Oth psychoactive substance use, unsp w withdrawal, uncomp |
'F19931' | Oth psychoactive substance use, unsp w withdrawal delirium |
'F19932' | Oth psychoactv sub use, unsp w w/drawal w perceptl disturb |
'F19939' | Other psychoactive substance use, unsp with withdrawal, unsp |
'F1994' | Oth psychoactive substance use, unsp w mood disorder |
'F19950' | Oth psychoactv sub use, unsp w psych disorder w delusions |
'F19951' | Oth psychoactv sub use, unsp w psych disorder w hallucin |
'F19959' | Oth psychoactv substance use, unsp w psych disorder, unsp |
'F1996' | Oth psychoactv sub use, unsp w persist amnestic disorder |
'F1997' | Oth psychoactive substance use, unsp w persisting dementia |
'F19980' | Oth psychoactive substance use, unsp w anxiety disorder |
'F19981' | Oth psychoactive substance use, unsp w sexual dysfunction |
'F19982' | Oth psychoactive substance use, unsp w sleep disorder |
'F19988' | Oth psychoactive substance use, unsp w oth disorder |
'F1999' | Oth psychoactive substance use, unsp w unsp disorder |
'F550' | Abuse of antacids |
'F551' | Abuse of herbal or folk remedies |
'F552' | Abuse of laxatives |
'F553' | Abuse of steroids or hormones |
'F554' | Abuse of vitamins |
'F558' | Abuse of other non-psychoactive substances |
'F630' | Pathological gambling |
'O355XX0' | Maternal care for (suspected) damage to fetus by drugs, unsp |
'O355XX1' | Maternal care for damage to fetus by drugs, fetus 1 |
'O355XX2' | Maternal care for damage to fetus by drugs, fetus 2 |
'O355XX3' | Maternal care for damage to fetus by drugs, fetus 3 |
'O355XX4' | Maternal care for damage to fetus by drugs, fetus 4 |
'O355XX5' | Maternal care for damage to fetus by drugs, fetus 5 |
'O355XX9' | Maternal care for (suspected) damage to fetus by drugs, oth |
'O99320' | Drug use complicating pregnancy, unspecified trimester |
'O99321' | Drug use complicating pregnancy, first trimester |
'O99322' | Drug use complicating pregnancy, second trimester |
'O99323' | Drug use complicating pregnancy, third trimester |
'O99324' | Drug use complicating childbirth |
'O99325' | Drug use complicating the puerperium |
'P0449' | Newborn affected by maternal use of other drugs of addiction |
'P962' | Withdrawal symptoms from therapeutic use of drugs in newborn |
'F1310' | Sedative, hypnotic or anxiolytic abuse, uncomplicated |
'F13120' | Sedatv/hyp/anxiolytc abuse w intoxication, uncomplicated |
'F13121' | Sedatv/hyp/anxiolytc abuse w intoxication delirium |
'F13129' | Sedative, hypnotic or anxiolytic abuse w intoxication, unsp |
'F1314' | Sedative, hypnotic or anxiolytic abuse w mood disorder |
'F13150' | Sedatv/hyp/anxiolytc abuse w psychotic disorder w delusions |
'F13151' | Sedatv/hyp/anxiolytc abuse w psychotic disorder w hallucin |
'F13159' | Sedatv/hyp/anxiolytc abuse w psychotic disorder, unsp |
'F13180' | Sedative, hypnotic or anxiolytic abuse w anxiety disorder |
'F13181' | Sedative, hypnotic or anxiolytic abuse w sexual dysfunction |
'F13182' | Sedative, hypnotic or anxiolytic abuse w sleep disorder |
'F13188' | Sedative, hypnotic or anxiolytic abuse w oth disorder |
'F1319' | Sedative, hypnotic or anxiolytic abuse w unsp disorder |
'F1320' | Sedative, hypnotic or anxiolytic dependence, uncomplicated |
'F13220' | Sedatv/hyp/anxiolytc dependence w intoxication, uncomp |
'F13221' | Sedatv/hyp/anxiolytc dependence w intoxication delirium |
'F13229' | Sedatv/hyp/anxiolytc dependence w intoxication, unsp |
'F13230' | Sedatv/hyp/anxiolytc dependence w withdrawal, uncomplicated |
'F13231' | Sedatv/hyp/anxiolytc dependence w withdrawal delirium |
'F13232' | Sedatv/hyp/anxiolytc depend w w/drawal w perceptual disturb |
'F13239' | Sedatv/hyp/anxiolytc dependence w withdrawal, unsp |
'F1324' | Sedative, hypnotic or anxiolytic dependence w mood disorder |
'F13250' | Sedatv/hyp/anxiolytc depend w psychotic disorder w delusions |
'F13251' | Sedatv/hyp/anxiolytc depend w psychotic disorder w hallucin |
'F13259' | Sedatv/hyp/anxiolytc dependence w psychotic disorder, unsp |
'F1326' | Sedatv/hyp/anxiolytc depend w persisting amnestic disorder |
'F1327' | Sedatv/hyp/anxiolytc dependence w persisting dementia |
'F13280' | Sedatv/hyp/anxiolytc dependence w anxiety disorder |
'F13281' | Sedatv/hyp/anxiolytc dependence w sexual dysfunction |
'F13282' | Sedative, hypnotic or anxiolytic dependence w sleep disorder |
'F13288' | Sedative, hypnotic or anxiolytic dependence w oth disorder |
'F1329' | Sedative, hypnotic or anxiolytic dependence w unsp disorder |
'F1390' | Sedative, hypnotic, or anxiolytic use, unsp, uncomplicated |
'F13920' | Sedatv/hyp/anxiolytc use, unsp w intoxication, uncomplicated |
'F13921' | Sedatv/hyp/anxiolytc use, unsp w intoxication delirium |
'F13929' | Sedatv/hyp/anxiolytc use, unsp w intoxication, unsp |
'F13930' | Sedatv/hyp/anxiolytc use, unsp w withdrawal, uncomplicated |
'F13931' | Sedatv/hyp/anxiolytc use, unsp w withdrawal delirium |
'F13932' | Sedatv/hyp/anxiolytc use, unsp w w/drawal w perceptl disturb |
'F13939' | Sedatv/hyp/anxiolytc use, unsp w withdrawal, unsp |
'F1394' | Sedative, hypnotic or anxiolytic use, unsp w mood disorder |
'F13950' | Sedatv/hyp/anxiolytc use, unsp w psych disorder w delusions |
'F13951' | Sedatv/hyp/anxiolytc use, unsp w psych disorder w hallucin |
'F13959' | Sedatv/hyp/anxiolytc use, unsp w psychotic disorder, unsp |
'F1396' | Sedatv/hyp/anxiolytc use, unsp w persist amnestic disorder |
'F1397' | Sedatv/hyp/anxiolytc use, unsp w persisting dementia |
'F13980' | Sedatv/hyp/anxiolytc use, unsp w anxiety disorder |
'F13981' | Sedatv/hyp/anxiolytc use, unsp w sexual dysfunction |
'F13982' | Sedative, hypnotic or anxiolytic use, unsp w sleep disorder |
'F13988' | Sedative, hypnotic or anxiolytic use, unsp w oth disorder |
'F1399' | Sedative, hypnotic or anxiolytic use, unsp w unsp disorder |
'F1410' | Cocaine abuse, uncomplicated |
'F14120' | Cocaine abuse with intoxication, uncomplicated |
'F14121' | Cocaine abuse with intoxication with delirium |
'F14122' | Cocaine abuse with intoxication with perceptual disturbance |
'F14129' | Cocaine abuse with intoxication, unspecified |
'F1414' | Cocaine abuse with cocaine-induced mood disorder |
'F14150' | Cocaine abuse w cocaine-induc psychotic disorder w delusions |
'F14151' | Cocaine abuse w cocaine-induc psychotic disorder w hallucin |
'F14159' | Cocaine abuse with cocaine-induced psychotic disorder, unsp |
'F14180' | Cocaine abuse with cocaine-induced anxiety disorder |
'F14181' | Cocaine abuse with cocaine-induced sexual dysfunction |
'F14182' | Cocaine abuse with cocaine-induced sleep disorder |
'F14188' | Cocaine abuse with other cocaine-induced disorder |
'F1419' | Cocaine abuse with unspecified cocaine-induced disorder |
'F1420' | Cocaine dependence, uncomplicated |
'F14220' | Cocaine dependence with intoxication, uncomplicated |
'F14221' | Cocaine dependence with intoxication delirium |
'F14222' | Cocaine dependence w intoxication w perceptual disturbance |
'F14229' | Cocaine dependence with intoxication, unspecified |
'F1423' | Cocaine dependence with withdrawal |
'F1424' | Cocaine dependence with cocaine-induced mood disorder |
'F14250' | Cocaine depend w cocaine-induc psych disorder w delusions |
'F14251' | Cocaine depend w cocaine-induc psychotic disorder w hallucin |
'F14259' | Cocaine dependence w cocaine-induc psychotic disorder, unsp |
'F14280' | Cocaine dependence with cocaine-induced anxiety disorder |
'F14281' | Cocaine dependence with cocaine-induced sexual dysfunction |
'F14282' | Cocaine dependence with cocaine-induced sleep disorder |
'F14288' | Cocaine dependence with other cocaine-induced disorder |
'F1429' | Cocaine dependence with unspecified cocaine-induced disorder |
'F1490' | Cocaine use, unspecified, uncomplicated |
'F14920' | Cocaine use, unspecified with intoxication, uncomplicated |
'F14921' | Cocaine use, unspecified with intoxication delirium |
'F14922' | Cocaine use, unsp w intoxication with perceptual disturbance |
'F14929' | Cocaine use, unspecified with intoxication, unspecified |
'F1494' | Cocaine use, unspecified with cocaine-induced mood disorder |
'F14950' | Cocaine use, unsp w cocaine-induc psych disorder w delusions |
'F14951' | Cocaine use, unsp w cocaine-induc psych disorder w hallucin |
'F14959' | Cocaine use, unsp w cocaine-induced psychotic disorder, unsp |
'F14980' | Cocaine use, unsp with cocaine-induced anxiety disorder |
'F14981' | Cocaine use, unsp with cocaine-induced sexual dysfunction |
'F14982' | Cocaine use, unspecified with cocaine-induced sleep disorder |
'F14988' | Cocaine use, unspecified with other cocaine-induced disorder |
'F1499' | Cocaine use, unsp with unspecified cocaine-induced disorder |
'F1510' | Other stimulant abuse, uncomplicated |
'F15120' | Other stimulant abuse with intoxication, uncomplicated |
'F15121' | Other stimulant abuse with intoxication delirium |
'F15122' | Oth stimulant abuse w intoxication w perceptual disturbance |
'F15129' | Other stimulant abuse with intoxication, unspecified |
'F1514' | Other stimulant abuse with stimulant-induced mood disorder |
'F15150' | Oth stimulant abuse w stim-induce psych disorder w delusions |
'F15151' | Oth stimulant abuse w stim-induce psych disorder w hallucin |
'F15159' | Oth stimulant abuse w stim-induce psychotic disorder, unsp |
'F15180' | Oth stimulant abuse with stimulant-induced anxiety disorder |
'F15181' | Oth stimulant abuse w stimulant-induced sexual dysfunction |
'F15182' | Other stimulant abuse with stimulant-induced sleep disorder |
'F15188' | Other stimulant abuse with other stimulant-induced disorder |
'F1519' | Other stimulant abuse with unsp stimulant-induced disorder |
'F1520' | Other stimulant dependence, uncomplicated |
'F15220' | Other stimulant dependence with intoxication, uncomplicated |
'F15221' | Other stimulant dependence with intoxication delirium |
'F15222' | Oth stimulant dependence w intox w perceptual disturbance |
'F15229' | Other stimulant dependence with intoxication, unspecified |
'F1523' | Other stimulant dependence with withdrawal |
'F1524' | Oth stimulant dependence w stimulant-induced mood disorder |
'F15250' | Oth stim depend w stim-induce psych disorder w delusions |
'F15251' | Oth stimulant depend w stim-induce psych disorder w hallucin |
'F15259' | Oth stimulant depend w stim-induce psychotic disorder, unsp |
'F15280' | Oth stimulant dependence w stim-induce anxiety disorder |
'F15281' | Oth stimulant dependence w stim-induce sexual dysfunction |
'F15282' | Oth stimulant dependence w stimulant-induced sleep disorder |
'F15288' | Oth stimulant dependence with oth stimulant-induced disorder |
'F1529' | Oth stimulant dependence w unsp stimulant-induced disorder |
'F1590' | Other stimulant use, unspecified, uncomplicated |
'F15920' | Other stimulant use, unsp with intoxication, uncomplicated |
'F15921' | Other stimulant use, unspecified with intoxication delirium |
'F15922' | Oth stimulant use, unsp w intox w perceptual disturbance |
'F15929' | Other stimulant use, unsp with intoxication, unspecified |
'F1594' | Oth stimulant use, unsp with stimulant-induced mood disorder |
'F15950' | Oth stim use, unsp w stim-induce psych disorder w delusions |
'F15951' | Oth stim use, unsp w stim-induce psych disorder w hallucin |
'F15959' | Oth stimulant use, unsp w stim-induce psych disorder, unsp |
'F15980' | Oth stimulant use, unsp w stimulant-induced anxiety disorder |
'F15981' | Oth stimulant use, unsp w stim-induce sexual dysfunction |
'F15982' | Oth stimulant use, unsp w stimulant-induced sleep disorder |
F15988' | th stimulant use, unsp with oth stimulant-induced disorder |
F1599' | th stimulant use, unsp with unsp stimulant-induced disorder |
P0441' | ewborn affected by maternal use of cocaine |
'T405X1A' | Poisoning by cocaine, accidental (unintentional), init |
'T405X3A' | Poisoning by cocaine, assault, initial encounter |
'T405X4A' | Poisoning by cocaine, undetermined, initial encounter |
'T405X5A' | Adverse effect of cocaine, initial encounter |
Dental Conditions ICD-10-CM Diagnosis Codes K000, K001, K002, K003, K004, K005, K006, K007, K008, K009, K010, K011, K023, K0251, K0252, K0253, K0261, K0262, K0263, K027, K029, K030, K031, K032, K033, K034, K035, K036, K037, K0381, K0389, K039, K0401, K0402, K041, K042, K043, K044, K045, K046, K047, K048, K0490, K0499, K0500, K0501, K0510, K0511, K0520, K05211, K05212, K05213, K05219, K05221, K05222, K05223, K05229, K0530, K05311, K05312, K05313, K05319, K05321, K05322, K05323, K05329, K054, K055, K056, K06010, K06011, K06012, K06013, K06020, K06021, K06022, K06023, K061, K062, K063, K068, K069. Injury ICD-10-CM Diagnosis Codes S00-S99; T07-T34; T36-T50 with a 6th character of 1,2, 3, or 4 (except T36.9, T37.9, T39.9, T41.4, T42.7, T43.9, T45.9, T47.9, and T49.9 with a 5th character of 1, 2, 3, or 4); T51-T65; T66-T76; T79; T84.01; T84.02; and O9A.2-O9A.5. Dementia ICD-10-CM Diagnosis Codes Table B-3: Dementia ICD-10-CM Diagnosis Codes |
ICD-10-CM DIAGNOSIS |
DESCRIPTION |
---|---|
Vascular dementia |
|
F0150 |
Vascular dementia without behavioral disturbance |
F0151 |
Vascular dementia with behavioral disturbance |
Dementia in other diseases classified elsewhere |
|
F0280 |
Dementia in other diseases classified elsewhere without behavioral disturbance |
F0281 |
Dementia in other diseases classified elsewhere with behavioral disturbance |
Unspecified dementia |
|
F0390 |
Unspecified dementia without behavioral disturbance |
F0391 |
Unspecified dementia with behavioral disturbance |
Delirium, not induced by alcohol and other psychoactive substances |
|
F05 |
Delirium due to known physiological condition |
Alzheimer's disease |
|
G300 |
Alzheimer's disease with early onset |
G301 |
Alzheimer's disease with late onset |
G308 |
Other Alzheimer's disease |
G309 |
Alzheimer's disease, unspecified |
Delivery and Abortion ICD-10-CM diagnoses, ICD-10-PCS procedures, and DRGs |
Any Indication of Delivery |
Any diagnosis of Z37X: Z370, Z371, Z372, Z373, Z374, Z3750, Z3751, Z3752, Z3753, Z3754, Z3759, Z3760, Z3761, Z3762, Z3763, Z3764, Z3769, Z377, Z379 |
Any diagnosis of O80 (vaginal delivery) |
Any diagnosis of O82, O7582 (C-section) |
Any procedure code of 10D00Z0-10D00Z2, 10D07Z3-0D07Z8, 10E0XZZ |
Any delivery DRG: 765-768 or 774-775 |
Excluding an Indication of Abortion |
Any diagnosis of 'O00', 'O01', 'O02', 'O03', 'O04', 'O07', 'O08' |
Any procedure starting with '10A0' ('10A00ZZ', '10A03ZZ', '10A04ZZ', '10A07Z6', '10A07ZW', '10A07ZX', '10A07ZZ', '10A08ZZ') |
Table E-2: Pulmonary Embolism or Deep Vein Thrombosis ICD-10-CM Diagnosis Codes |
ICD-10-CM Diagnosis Codes |
I2602 =Saddle embolus of pulmonary artery with acute corpulmonale |
I2609 =Other pulmonary embolism with acute corpulmonale |
I2692 =Saddle embolus of pulmonary artery without acute corpulmonale |
I2699 =Other pulmonary embolism without acute corpulmonale |
I8010 =Phlebitis and thrombophlebitis of unspecified femoral vein |
I8011 =Phlebitis and thrombophlebitis of right femoral vein |
I8012 =Phlebitis and thrombophlebitis of left femoral vein |
I8013 =Phlebitis and thrombophlebitis of femoral vein, bilateral |
I80201 =Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity |
I80202 =Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity |
I80203 =Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral |
I80209 =Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity |
I80211 =Phlebitis and thrombophlebitis of right iliac vein |
I80212 =Phlebitis and thrombophlebitis of left iliac vein |
I80213 =Phlebitis and thrombophlebitis of iliac vein, bilateral |
I80219 =Phlebitis and thrombophlebitis of unspecified iliac vein |
I80221 =Phlebitis and thrombophlebitis of right popliteal vein |
I80222 =Phlebitis and thrombophlebitis of left popliteal vein |
I80223 =Phlebitis and thrombophlebitis of popliteal vein, bilateral |
I80229 =Phlebitis and thrombophlebitis of unspecified popliteal vein |
I80231 =Phlebitis and thrombophlebitis of right tibial vein |
I80232 =Phlebitis and thrombophlebitis of left tibial vein |
I80233 =Phlebitis and thrombophlebitis of tibial vein, bilateral |
I80239 =Phlebitis and thrombophlebitis of unspecified tibial vein |
I80291 =Phlebitis and thrombophlebitis of other deep vessels of right lower extremity |
I80292 =Phlebitis and thrombophlebitis of other deep vessels of left lower extremity |
I80293 =Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral |
I80299 =Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity |
I82401 =Acute embolism and thrombosis of unspecified deep veins of right lower extremity |
I82402 =Acute embolism and thrombosis of unspecified deep veins of left lower extremity |
I82403 =Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral |
I82409 =Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity |
I82411 =Acute embolism and thrombosis of right femoral vein |
I82412 =Acute embolism and thrombosis of left femoral vein |
I82413 =Acute embolism and thrombosis of femoral vein, bilateral |
I82419 =Acute embolism and thrombosis of unspecified femoral vein |
I82421 =Acute embolism and thrombosis of right iliac vein |
I82422 =Acute embolism and thrombosis of left iliac vein |
I82423 =Acute embolism and thrombosis of iliac vein, bilateral |
I82429 =Acute embolism and thrombosis of unspecified iliac vein |
I82431 =Acute embolism and thrombosis of right popliteal vein |
I82432 =Acute embolism and thrombosis of left popliteal vein |
I82433 =Acute embolism and thrombosis of popliteal vein, bilateral |
I82439 =Acute embolism and thrombosis of unspecified popliteal vein |
I824Y1 =Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity |
I824Y2 =Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity |
I824Y3 =Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral |
I824Y9 =Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity |
Table E-3: Postpartum Hemorrhage ICD-10-CM Diagnosis Codes |
ICD-10-CM Diagnosis Codes | Description |
---|---|
O43.212 | Placenta accreta, second trimester |
O43.213 | Placenta accreta, third trimester |
O43.219 | Placenta accreta, unspecified trimester |
O43.222 | Placenta increta, second trimester |
O43.223 | Placenta increta, third trimester |
O43.229 | Placenta increta, unspecified trimester |
O43.232 | Placenta percreta, second trimester |
O43.233 | Placenta percreta, third trimester |
O43.239 | Placenta percreta, unspecified trimester |
O72.0 | Third-stage hemorrhage |
O72.1 | Other immediate postpartum hemorrhage |
O72.2 | Delayed and secondary postpartum hemorrhage |
O72.3 | Postpartum coagulation defects |
Table E-4: Eclampsia or Preeclampsia ICD-10-CM Diagnosis Codes |
ICD-10-CM Diagnosis Codes |
---|
Any diagnosis starting with 'O14' for pre-eclampsia |
Any diagnosis starting with 'O15' for eclampsia |
Any diagnosis starting with 'O11' for pre-existing hypertension with pre-eclampsia |
1ICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification. 2 ICD-10-CM/PCS: International Classification of Diseases, Tenth Revision, Clinical Modification and Procedure Coding System. 3 Some diagnoses are exempt from having POA reported. 4 Community hospitals are defined by the AHA as "all non-Federal, short-term, general, and other specialty hospitals, excluding hospital units of institutions open to the public." Specialty hospitals included in the AHA definition of "community hospitals" are: obstetrics-gynecology, ear-nose-throat, short-term rehabilitation, orthopedic, and pediatric institutions. Community hospitals can include rehabilitation and long-term acute care (LTAC) facilities. These facilities can provide acute care services to patients who need long term hospitalization). Excluded from the AHA definition of "community hospitals" are long-term non-acute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment facilities. 5 HCUP Cost-to-Charge Ratio Files. Healthcare Cost and Utilization Project (HCUP). December 2019. Agency for Healthcare Research and Quality, Rockville, MD. Available: www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. |
Internet Citation: Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2022 National Healthcare Quality and Disparities Report (NHQDR). Healthcare Cost and Utilization Project (HCUP). October 2022. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/reports/methods/MS2022-01-NHQDRMethodsReport.jsp. |
Are you having problems viewing or printing pages on this website? |
If you have comments, suggestions, and/or questions, please contact hcup@ahrq.gov. |
Privacy Notice, Viewers & Players |
Last modified 10/17/22 |